Research Project Awards
2015 (Cycle 24)
Using technology to help low-income and Latino smokers quit | 2015 (Cycle 24) | $488,628 |
Palo Alto University, Inc. | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
Metabolic consequences of tobacco toxicants | 2015 (Cycle 24) | $421,875 |
University of California, San Diego | Early Diagnosis/Pathogenesis | |
Genotoxicity and Novel Biomarkers of Thirdhand Smoke | 2015 (Cycle 24) | $644,618 |
Lawrence Berkeley National Laboratory | Environmental Exposure/Toxicology | |
Air pollution, tobacco smoke, & asthma in minority children | 2015 (Cycle 24) | $412,913 |
University of California, San Francisco | Environmental Exposure/Toxicology | |
Electronic Nicotine Delivery Systems and California Youth | 2015 (Cycle 24) | $545,532 |
HBSA, Inc. | Regulatory Science/New Products | |
Prevention of relapse in nicotine dependence: role of mGluR7 | 2015 (Cycle 24) | $421,875 |
University of California, San Diego | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
Tobacco Treatment for Employable Californians | 2015 (Cycle 24) | $573,934 |
Stanford University | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
The Role of CSN6 in Cardiac Muscle and Sudden Cardiac Death | 2015 (Cycle 24) | $421,875 |
University of California, San Diego | Early Diagnosis/Pathogenesis | |
Controlled Thirdhand Smoke Exposure Core | 2015 (Cycle 24) | $304,957 |
University of California, San Francisco | Environmental Exposure/Toxicology | |
The Cost of Smoking for CA's Racial/Ethnic Communities | 2015 (Cycle 24) | $165,972 |
University of California, San Francisco | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
Airway inflammation in the evolution of airway fibrosis | 2015 (Cycle 24) | $421,284 |
University of California, San Francisco | Early Diagnosis/Pathogenesis | |
A novel imaging technology for the early detection of Oral C | 2015 (Cycle 24) | $421,842 |
University of California, Los Angeles | Early Diagnosis/Pathogenesis | |
Cytotoxicity and Stress Induction by Thirdhand Smoke | 2015 (Cycle 24) | $444,081 |
University of California, Riverside | Environmental Exposure/Toxicology | |
Role of Glutamate/ACh co-release in nicotine addiction | 2015 (Cycle 24) | $421,875 |
University of California, San Diego | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
Smoking and Embryonal Tumor Study | 2015 (Cycle 24) | $450,835 |
University of California, Los Angeles | Regulatory Science/New Products | |
Population studies of new tobacco products and cigarettes | 2015 (Cycle 24) | $406,492 |
University of California, San Diego | Regulatory Science/New Products | |
DUAL USE OF MARIJUANA AND TOBACCO: SOCIAL MEDIA AND YOUTH | 2015 (Cycle 24) | $566,562 |
HBSA, Inc. | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
The role of PACAP/PAC1 receptor system in nicotine addiction | 2015 (Cycle 24) | $490,832 |
Western University of Health Sciences | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
2014 (Cycle 23)
Perinatal Tobacco Exposure Epigenetics & Transgenerational | 2014 (Cycle 23) | $445,312 |
LA Biomedical Research Institute at Harbor-UCLA Medical Center | Environmental Exposure/Toxicology | |
Tobacco Use Disparities in Californias Priority Populations | 2014 (Cycle 23) | $127,634 |
Claremont Graduate University | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
Early Diagnosis/Pathogenesis of Tobacco-Related Lung Disease | 2014 (Cycle 23) | $675,093 |
Scripps Research Institute | Early Diagnosis/Pathogenesis | |
ENDS on campus: Changes in policy and retail environments | 2014 (Cycle 23) | $527,296 |
Stanford University | Industry Influence/Policy | |
Genomic Signatures of CVD in Twins Discordant for Smoking | 2014 (Cycle 23) | $461,488 |
University of California, San Diego | Early Diagnosis/Pathogenesis | |
Assessing Toxicity of Tobacco Product Waste to Humans | 2014 (Cycle 23) | $527,249 |
San Diego State University Research Foundation | Environmental Exposure/Toxicology | |
Biological Impact of E-Cigarettes on Lung Carcinogenesis | 2014 (Cycle 23) | $444,879 |
University of California, Los Angeles | Regulatory Science/New Products | |
Tobacco Use Disparities in California's Priority Populations | 2014 (Cycle 23) | $326,069 |
University of California, San Diego | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
2013 (Cycle 22)
Developmental Nicotine Exposure and Addiction | 2013 (Cycle 22) | $348,348 |
University of California, Los Angeles | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
Developmental Nicotine Exposure and Addiction | 2013 (Cycle 22) | $102,816 |
University of California, Irvine | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
Ultra Low Dose, Effective CT for Lung Cancer Screening | 2013 (Cycle 22) | $420,238 |
University of California, Los Angeles | Early Diagnosis/Pathogenesis | |
Social media messaging and public health campaigns: Prop 29 | 2013 (Cycle 22) | $290,315 |
University of California, San Diego | Industry Influence/Policy | |
Economic impact of tobacco taxes on African Americans | 2013 (Cycle 22) | $467,178 |
University of California, San Francisco | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
Shared Genetics of COPD and Lung Cancer | 2013 (Cycle 22) | $549,561 |
Kaiser Foundation Research Institute | Early Diagnosis/Pathogenesis | |
Metals and nanoparticles in electronic cigarette aerosol | 2013 (Cycle 22) | $264,176 |
University of California, Riverside | Regulatory Science/New Products | |
Effects of THS toxins on mechanical and drug-induced injury | 2013 (Cycle 22) | $450,896 |
University of California, Riverside | Environmental Exposure/Toxicology | |
GIS tools for surveillance and regulation of flavored OTPs | 2013 (Cycle 22) | $553,520 |
Stanford University | Industry Influence/Policy | |
African American Perceptions of Tobacco Denormalization Approaches | 2013 (Cycle 22) | $600,361 |
HBSA, Inc. | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
Toward Smoke-Free Casinos: The Win-River Experience | 2013 (Cycle 22) | $269,209 |
San Diego State University Research Foundation | Environmental Exposure/Toxicology | |
Early Detection of Stroke and Cardiovascular Disease Risk | 2013 (Cycle 22) | $586,770 |
Children's Hospital Oakland Research Institute | Early Diagnosis/Pathogenesis | |
Joint roles of ceramide, EGFR/Src in lung injury and cancer | 2013 (Cycle 22) | $467,498 |
University of California, Davis | Early Diagnosis/Pathogenesis | |
Health and economic toll of tobacco on CA's LGBT community | 2013 (Cycle 22) | $375,845 |
University of California, San Francisco | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
A Family-Based Approach To Reduce Smoking in Vietnamese Men | 2013 (Cycle 22) | $508,987 |
University of California, San Francisco | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
2012 (Cycle 21)
Certifying Smoke-Free Used Cars | 2012 (Cycle 21) | $686,734 |
San Diego State University Research Foundation | Industry Influence/Policy | |
Preventing and Reducing Tobacco Use Among Homeless Youth | 2012 (Cycle 21) | $879,484 |
RAND Corporation | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
Non-Nicotine Tobacco Constituents in Reward: Age Effects | 2012 (Cycle 21) | $275,155 |
University of California, Irvine | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
Suppression of lung adenocarcinoma by miR-34 microRNAs | 2012 (Cycle 21) | $459,900 |
University of California, Berkeley | Early Diagnosis/Pathogenesis | |
African American Smoking and Quitting in California | 2012 (Cycle 21) | $382,402 |
Claremont Graduate University | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
Clinical Validation of Salivary Oral Cancer Biomarkers | 2012 (Cycle 21) | $521,831 |
University of California, Los Angeles | Early Diagnosis/Pathogenesis | |
Fotonovela to prevent SHS exposure in multiunit housing | 2012 (Cycle 21) | $785,104 |
University of Southern California | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
Third hand smoke and hypersensitivity | 2012 (Cycle 21) | $668,192 |
Stanford University | Environmental Exposure/Toxicology | |
Barriers to Blue-Collar HMO Smoking Cessation Participation | 2012 (Cycle 21) | $710,025 |
HBSA, Inc. | Disparities /Prevention/ Cessation/ Nicotine Dependence | |
Tobacco control policy and population-level harm reduction | 2012 (Cycle 21) | $459,900 |
University of California, San Diego | Regulatory Science/New Products | |
2008 (Cycle 17)
Chronic nicotine treatment in primates; role of a6b2 nAChRs | 2008 (Cycle 17) | $382,500 |
SRI International | Nicotine Dependence | |
Smokefree Homes and Smoking Initiation in a National Sample | 2008 (Cycle 17) | $477,781 |
University of California, San Diego | Public Health, Public Policy, and Economics | |
Smoking Policies and Secondhand Smoke in Hotel Rooms | 2008 (Cycle 17) | $522,544 |
San Diego State University Research Foundation | Public Health, Public Policy, and Economics | |
Analysis of the Hippo pathway in lung cancer | 2008 (Cycle 17) | $654,999 |
Beckman Research Institute of the City of Hope | Cancer | |
Chronic nicotine treatment in primates; role of a6b2 nAChRs | 2008 (Cycle 17) | $194,628 |
The Parkinson's Institute | Nicotine Dependence | |
ApoE related effect of smoking in cardiovascular disease | 2008 (Cycle 17) | $678,561 |
Children's Hospital Oakland Research Institute | Cardiovascular Disease | |
Dissemination of the Rx for Change in Psychiatry Curriculum | 2008 (Cycle 17) | $30,177 |
Stanford University | Tobacco-Use Prevention and Cessation | |
Role of oxidative stress and mitochondria in COPD | 2008 (Cycle 17) | $615,251 |
University of Southern California | General Biomedical Science | |
Tobacco, Nitrosamines, Damage, Repair, Mutations, and Cancer | 2008 (Cycle 17) | $654,674 |
Beckman Research Institute of the City of Hope | Cancer | |
Pharmacogenomics of New Generation Platinums in Lung Cancer | 2008 (Cycle 17) | $394,380 |
University of California, San Francisco | Cancer | |
Low-Cost Contingency Management for Smoking Cessation | 2008 (Cycle 17) | $478,743 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Cigarette smoke injures lung epithelium by activating nSMase | 2008 (Cycle 17) | $394,380 |
University of California, Davis | Pulmonary Disease | |
The impact of secondhand smoke exposure on COPD outcomes | 2008 (Cycle 17) | $492,890 |
University of California, San Francisco | Epidemiology | |
Nicotine Self-Administration in an Animal Model | 2008 (Cycle 17) | $720,434 |
Scripps Research Institute | Nicotine Dependence | |
Nicotine and congenital heart disease | 2008 (Cycle 17) | $629,797 |
Stanford University | Cardiovascular Disease | |
A Novel Approach to Prevent in Utero Nicotine Lung Injury | 2008 (Cycle 17) | $564,957 |
LA Biomedical Research Institute at Harbor-UCLA Medical Center | General Biomedical Science | |
Preserving At Risk Tobacco Control Policy Resources | 2008 (Cycle 17) | $392,644 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Dissemination of the Rx for Change in Psychiatry Curriculum | 2008 (Cycle 17) | $409,106 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Association of Outlet Density with Smoking and Pack Price | 2008 (Cycle 17) | $515,010 |
Stanford University | Public Health, Public Policy, and Economics | |
Novel Extracellular Sulfatases and Smoke-induced Lung Cancer | 2008 (Cycle 17) | $394,380 |
University of California, San Francisco | Cancer | |
Nicotinic receptors in nicotine addiction | 2008 (Cycle 17) | $634,743 |
California Institute of Technology | Nicotine Dependence | |
Negative effects of smoke on novel HDL mimetic therapies | 2008 (Cycle 17) | $657,970 |
Lawrence Berkeley National Laboratory | Cardiovascular Disease | |
Measuring prenatal tobacco exposure in newborn blood spots | 2008 (Cycle 17) | $506,839 |
Sequoia Foundation | Epidemiology | |
2007 (Cycle 16)
Modulating TLR9 Activation for Lung Cancer Therapy | 2007 (Cycle 16) | $246,467 |
Scripps Research Institute | Cancer | |
Nicotinic Manipulation of the Hippocampus | 2007 (Cycle 16) | $420,000 |
University of California, San Diego | Nicotine Dependence | |
Modulating TLR9 Activation for Lung Cancer Therapy | 2007 (Cycle 16) | $100,481 |
Sidney Kimmel Cancer Center | Cancer | |
Tobacco Industry Targeting of Older Persons | 2007 (Cycle 16) | $509,993 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Social Context of Smoking in Adolescence and Young Adulthood | 2007 (Cycle 16) | $791,718 |
RAND Corporation | Epidemiology | |
Impact of MPO in Tobacco-related Cardiovascular Disease | 2007 (Cycle 16) | $545,359 |
Sidney Kimmel Cancer Center | Cardiovascular Disease | |
Exposure to Secondhand Smoke: Effects of Proximity | 2007 (Cycle 16) | $628,932 |
Stanford University | Public Health, Public Policy, and Economics | |
Impact of MPO in Tobacco-related Cardiovascular Disease | 2007 (Cycle 16) | $267,555 |
The Burnham Institute for Medical Research | Cardiovascular Disease | |
Brain nAChR Occupancy: Effect of Secondhand Smoke | 2007 (Cycle 16) | $623,593 |
Brentwood Biomedical Research Institute | Nicotine Dependence | |
Economic Impact of Secondhand Smoke for Communities of Color | 2007 (Cycle 16) | $216,038 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Macrophage DAP12 pathway in emphysema | 2007 (Cycle 16) | $387,237 |
University of California, San Francisco | Pulmonary Disease | |
Molecular Dynamics & Regulation of Apo A-I's Conformation | 2007 (Cycle 16) | $644,293 |
Children's Hospital Oakland Research Institute | Cardiovascular Disease | |
Effects of nicotine on fetal hematopoiesis | 2007 (Cycle 16) | $764,400 |
Torrey Pines Institute for Molecular Studies | General Biomedical Science | |
High Resolution OCT for Early Airway Cancer Detection | 2007 (Cycle 16) | $480,636 |
University of California, Irvine | Cancer | |
Modulating TLR9 Activation for Lung Cancer Therapy | 2007 (Cycle 16) | $415,463 |
The Burnham Institute for Medical Research | Cancer | |
Understanding Nicotinic Receptor Subtype Specificity | 2007 (Cycle 16) | $592,751 |
California Institute of Technology | Nicotine Dependence | |
Hypnosis for Smoking Relapse Prevention | 2007 (Cycle 16) | $506,230 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Epigenetic Regulation of Airway MUC gene expression by smoke | 2007 (Cycle 16) | $419,528 |
University of California, Davis | Pulmonary Disease | |
Toxic and irritant pollutants from aged secondhand smoke | 2007 (Cycle 16) | $715,914 |
Lawrence Berkeley National Laboratory | General Biomedical Science | |
Gastroschisis: maternal smoking and genetic variation | 2007 (Cycle 16) | $668,429 |
Children's Hospital Oakland Research Institute | General Biomedical Science | |
2006 (Cycle 15)
Pharmacogenetics of Smoking Cessation | 2006 (Cycle 15) | $653,384 |
Stanford University | Tobacco-Use Prevention and Cessation | |
Culture and Tobacco Among American Indian Adolescents | 2006 (Cycle 15) | $824,825 |
University of Southern California | Epidemiology | |
Effect of Maternal Smoking on Early Human Development | 2006 (Cycle 15) | $489,025 |
University of California, San Francisco | General Biomedical Science | |
Activation and detoxification of lung cancer carcinogens | 2006 (Cycle 15) | $420,000 |
University of California, San Diego | Cancer | |
Immune Targeted Therapy for Lung Cancer | 2006 (Cycle 15) | $419,500 |
University of California, Los Angeles | Cancer | |
Genes affecting nicotine response in C. elegans | 2006 (Cycle 15) | $100,000 |
University of California, San Diego | Nicotine Dependence | |
Cotinine Metabolism in Infants and Children | 2006 (Cycle 15) | $509,473 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Unraveling lung cancer signaling pathways | 2006 (Cycle 15) | $780,780 |
Scripps Research Institute | Cancer | |
Simple Exposure Indicators for Secondhand Tobacco Smoke | 2006 (Cycle 15) | $280,684 |
Lawrence Berkeley National Laboratory | General Biomedical Science | |
Nicotine-dependent recruitment of vascular progenitor cells | 2006 (Cycle 15) | $799,907 |
The Burnham Institute for Medical Research | Cardiovascular Disease | |
NF-kB mediated inflammation in tobacco-induced lung cancer | 2006 (Cycle 15) | $420,000 |
University of California, San Diego | Cancer | |
Neurobiological substrates of nicotine addiction | 2006 (Cycle 15) | $419,503 |
University of California, San Diego | Nicotine Dependence | |
Clinical Pharmacology of Tobacco Alkaloids | 2006 (Cycle 15) | $508,848 |
University of California, San Francisco | General Biomedical Science | |
Smoking Policies and Secondhand Smoke in Rental Cars | 2006 (Cycle 15) | $609,852 |
San Diego State University Research Foundation | Public Health, Public Policy, and Economics | |
Sociocultural Determinants of Menthol Smoking Among Blacks | 2006 (Cycle 15) | $746,567 |
Charles R. Drew University of Medicine & Science | Epidemiology | |
Oxidative stress and skeletal muscle dysfunction in COPD | 2006 (Cycle 15) | $569,914 |
University of California, San Diego | Pulmonary Disease | |
Sex differences in nicotine effects on inflammation | 2006 (Cycle 15) | $410,570 |
University of California, San Francisco | Cardiovascular Disease | |
Mechanisms of targeted therapy resistance in lung cancer | 2006 (Cycle 15) | $358,500 |
University of California, Los Angeles | Cancer | |
Use of Existing Data to Develop Tobacco Control Strategies | 2006 (Cycle 15) | $418,699 |
University of California, San Diego | Public Health, Public Policy, and Economics | |
Reaching and Treating LGBT Smokers: The Internet and NRT | 2006 (Cycle 15) | $509,201 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
2005 (Cycle 14)
Heparan sulfate small molecules for contro tumor cell growth | 2005 (Cycle 14) | $626,807 |
California Institute of Technology | General Biomedical Science | |
Nicotine & behavioral regulation in adult ADHD | 2005 (Cycle 14) | $495,079 |
University of California, Irvine | Tobacco-Use Prevention and Cessation | |
Diabetes & tobacco exposure in So CA American Indians | 2005 (Cycle 14) | $468,020 |
University of California, San Diego | Epidemiology | |
Effects of Outlet/Ad Density on Teen Smking and Brand Choice | 2005 (Cycle 14) | $410,979 |
Stanford University | Public Health, Public Policy, and Economics | |
Role of Pneumocystis in COPD Progression | 2005 (Cycle 14) | $512,737 |
University of Southern California | Pulmonary Disease | |
Use of entertainment education on TV to deter youth smoking | 2005 (Cycle 14) | $509,320 |
University of California, Irvine | Public Health, Public Policy, and Economics | |
Improved chemoradiotherapy of lung cancer | 2005 (Cycle 14) | $659,033 |
California Pacific Medical Center Research Institute | Cancer | |
ETS Effects on Lung Surfactant | 2005 (Cycle 14) | $418,874 |
University of California, Santa Barbara | General Biomedical Science | |
Regulations of phase II genes by oxidation products | 2005 (Cycle 14) | $419,057 |
University of California, Merced | General Biomedical Science | |
Human oocyte development and PAH exposure | 2005 (Cycle 14) | $260,944 |
University of California, San Francisco | General Biomedical Science | |
A stage-based scheduled smoking intervention for Chinese | 2005 (Cycle 14) | $554,500 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Context & consequenes of smoking in a blue-collar cohort | 2005 (Cycle 14) | $426,555 |
Pacific Institute for Research and Evaluation | Epidemiology | |
cGMP regulation of vascular smooth muscle differentiation | 2005 (Cycle 14) | $403,818 |
University of California, San Diego | Cardiovascular Disease | |
Human oocyte development and PAH exposure | 2005 (Cycle 14) | $158,034 |
Stanford University | General Biomedical Science | |
Neuronal oxidative stress from mild carbon monoxide exposure | 2005 (Cycle 14) | $417,403 |
University of California, Los Angeles | General Biomedical Science | |
Mild carbon monoxide exposure impairs the inner ear | 2005 (Cycle 14) | $397,297 |
University of California, Los Angeles | General Biomedical Science | |
Role of protein phosphatase 2A in lung cancer | 2005 (Cycle 14) | $384,497 |
University of California, San Diego | Cancer | |
Relationship of perceived risks and benefits to teen smoking | 2005 (Cycle 14) | $532,037 |
University of California, San Francisco | Epidemiology | |
A novel approach to prevent in utero nicotine lung injury | 2005 (Cycle 14) | $597,916 |
LA Biomedical Research Institute at Harbor-UCLA Medical Center | General Biomedical Science | |
Conformationally constrained nicotine vaccines | 2005 (Cycle 14) | $778,921 |
Scripps Research Institute | Nicotine Dependence | |
Effect of smoke and gender on bronchiolar injury and repair | 2005 (Cycle 14) | $418,207 |
University of California, Davis | Pulmonary Disease | |
SHS Exacerbates cerebral ischemia: endothelial mechanisms | 2005 (Cycle 14) | $654,849 |
Stanford University | Cardiovascular Disease | |
2004 (Cycle 13)
COX-2 regulation of vaccination responses in lung cancer | 2004 (Cycle 13) | $379,362 |
University of California, Los Angeles | Cancer | |
Lesbian, gay, bisexual and transgender tobacco use | 2004 (Cycle 13) | $302,119 |
Kaiser Foundation Research Institute | Epidemiology | |
Lifetime passive smoke exposure and breast cancer in the CTS | 2004 (Cycle 13) | $285,300 |
Cancer Prevention Institute of California | Epidemiology | |
Internet health research center: smoking, Latinos, & the Web | 2004 (Cycle 13) | $535,096 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Disproportionate cost of smoking for communities of color | 2004 (Cycle 13) | $278,980 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Women and smoking: from adolescence to young adulthood | 2004 (Cycle 13) | $737,742 |
RAND Corporation | Epidemiology | |
Tobacco exposure in pregnant women in minority populations | 2004 (Cycle 13) | $469,727 |
Sequoia Foundation | Epidemiology | |
Effects of tobacco-induced gamete damage on embryogenesis | 2004 (Cycle 13) | $158,853 |
Lawrence Livermore National Laboratory | General Biomedical Science | |
SHS enhances cough via plasticity of brainstem neurons | 2004 (Cycle 13) | $387,150 |
University of California, Davis | Pulmonary Disease | |
Ethnicity and school-level effect on CA student tobacco use | 2004 (Cycle 13) | $420,713 |
University of California, Los Angeles | Epidemiology | |
Supply & demand for tobacco dependence coverage | 2004 (Cycle 13) | $89,145 |
University of California, Berkeley | Public Health, Public Policy, and Economics | |
Environmental contexts of smoking for Southeast Asians | 2004 (Cycle 13) | $726,834 |
Pacific Institute for Research and Evaluation | Epidemiology | |
Effects of tobacco-induced gamete damage on embryogenesis | 2004 (Cycle 13) | $607,787 |
Lawrence Berkeley National Laboratory | General Biomedical Science | |
Nonsmokers helping smokers and the role of culture | 2004 (Cycle 13) | $476,656 |
University of California, San Diego | Tobacco-Use Prevention and Cessation | |
Vitamin A derivatives as antagonists of nicotine effects | 2004 (Cycle 13) | $670,085 |
The Burnham Institute for Medical Research | Cancer | |
Corporate strategies: design, conduct, publication of research | 2004 (Cycle 13) | $407,567 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Lifetime passive smoke exposure and breast cancer in the CTS | 2004 (Cycle 13) | $122,659 |
Public Health Institute | Epidemiology | |
Fertility smoking and early mammalian development | 2004 (Cycle 13) | $392,451 |
University of California, Riverside | General Biomedical Science | |
How do nic and cig smoke affect neural control of breathing? | 2004 (Cycle 13) | $392,620 |
University of California, Los Angeles | Pulmonary Disease | |
Exposed children to secondhand smoke through contaminated homes | 2004 (Cycle 13) | $754,504 |
San Diego State University Research Foundation | Epidemiology | |
Effects of pro and anti-smoking cues in stores on craving | 2004 (Cycle 13) | $373,894 |
Stanford University | Public Health, Public Policy, and Economics | |
IAP Antagonists for lung cancer treatment | 2004 (Cycle 13) | $727,658 |
The Burnham Institute for Medical Research | Cancer | |
Preserving at-risk tobacco control policy resources | 2004 (Cycle 13) | $392,344 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Oral clefts, smoking & variation of toxin biotransformation | 2004 (Cycle 13) | $623,472 |
Children's Hospital Oakland Research Institute | General Biomedical Science | |
Effectiveness of a large prenatal tobacco reduction program | 2004 (Cycle 13) | $425,181 |
Sequoia Foundation | Epidemiology | |
Tobacco use and atherosclerosis protection by paraoxonase | 2004 (Cycle 13) | $729,234 |
Scripps Research Institute | Cardiovascular Disease | |
The role of PARC in pulmonary inflammation | 2004 (Cycle 13) | $812,863 |
La Jolla Institute for Molecular Medicine | Pulmonary Disease | |
2003 (Cycle 12)
Geography of underage tobacco retail sales in Los Angeles | 2003 (Cycle 12) | $622,260 |
Pacific Institute for Research and Evaluation | Public Health, Public Policy, and Economics | |
Smoking, insulin resistance, and endothelial dysfunction | 2003 (Cycle 12) | $814,989 |
Stanford University | Cardiovascular Disease | |
Smoking cessation and medical care use/costs in a large HMO | 2003 (Cycle 12) | $337,964 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Passive smoking, inflammatory markers and childhood asthma | 2003 (Cycle 12) | $508,299 |
University of California, San Diego | Epidemiology | |
Nicotine self-administration in an animal model | 2003 (Cycle 12) | $660,156 |
Scripps Research Institute | Nicotine Dependence | |
Novel Office-Based Device for Imaging Vocal Cord Cancer | 2003 (Cycle 12) | $510,000 |
University of California, Irvine | Cancer | |
LDL pathophysiology and lipoprotein structure | 2003 (Cycle 12) | $527,245 |
Children's Hospital Oakland Research Institute | Cardiovascular Disease | |
Tobacco smoke and airway remodeling in asthma | 2003 (Cycle 12) | $418,951 |
University of California, San Diego | Pulmonary Disease | |
Does tobacco exposure delay conception? | 2003 (Cycle 12) | $447,845 |
Sequoia Foundation | Epidemiology | |
Bupropion for hospital-based smoking cessation | 2003 (Cycle 12) | $478,065 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Correlates of cigarette craving in acute nicotine withdrawal | 2003 (Cycle 12) | $17,000 |
University of California, Los Angeles | Nicotine Dependence | |
Birth defects, smoking and host susceptibility | 2003 (Cycle 12) | $466,200 |
March of Dimes Birth Defects Foundation | Epidemiology | |
Hyperactive nicotine receptors | 2003 (Cycle 12) | $675,487 |
California Institute of Technology | Nicotine Dependence | |
Chemotherapeutic inhibition of polysialic acid biosynthesis | 2003 (Cycle 12) | $420,781 |
University of California, Davis | Cancer | |
Effect of maternal smoking on early human development | 2003 (Cycle 12) | $505,975 |
University of California, San Francisco | General Biomedical Science | |
Correlates of cigarette craving in acute nicotine withdrawal | 2003 (Cycle 12) | $517,818 |
Brentwood Biomedical Research Institute | Nicotine Dependence | |
California AB13 compliance and ethnicity in urban bars | 2003 (Cycle 12) | $769,266 |
Pacific Institute for Research and Evaluation | Public Health, Public Policy, and Economics | |
Controlled study of withdrawal symptoms in teen smokers | 2003 (Cycle 12) | $499,890 |
Stanford University | Nicotine Dependence | |
Smoking prevention for Asian-American college students | 2003 (Cycle 12) | $679,368 |
Veterans Medical Research Foundation | Tobacco-Use Prevention and Cessation | |
Neurobiological substrates of nicotine addiction | 2003 (Cycle 12) | $723,613 |
Scripps Research Institute | Nicotine Dependence | |
Use of existing data to dvlp new tobacco control strategies | 2003 (Cycle 12) | $419,888 |
University of California, San Diego | Public Health, Public Policy, and Economics | |
Integrins and drug resistance in small cell lung cancer | 2003 (Cycle 12) | $780,144 |
The Burnham Institute for Medical Research | Cancer | |
Protective function of VEGF on the development of emphysema | 2003 (Cycle 12) | $420,000 |
University of California, San Diego | Pulmonary Disease | |
Novel DNA vaccines for the treatment of lung cancer | 2003 (Cycle 12) | $783,900 |
Scripps Research Institute | Cancer | |
Tobacco use among American Indian adolescents in California | 2003 (Cycle 12) | $368,975 |
University of Southern California | Epidemiology | |
2002 (Cycle 11)
Tobacco industry responses to industry-focused campaigns | 2002 (Cycle 11) | $77,806 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Tobacco use & policies: San Diego Mexican American residents | 2002 (Cycle 11) | $786,750 |
San Diego State University Research Foundation | Public Health, Public Policy, and Economics | |
Irritant and analgesic effects of nicotine | 2002 (Cycle 11) | $226,650 |
University of California, Davis | Nicotine Dependence | |
Tobacco Alteration of TGF Beta3 Control of Palatogenesis | 2002 (Cycle 11) | $680,175 |
University of Southern California | General Biomedical Science | |
Nicotine and cardiac vulnerability to fibrillation | 2002 (Cycle 11) | $641,821 |
Cedars-Sinai Medical Center | Cardiovascular Disease | |
Environmental tobacco smoke effects on lung surfactant | 2002 (Cycle 11) | $406,444 |
University of California, Santa Barbara | Pulmonary Disease | |
Role of protein phosphatase 2A in lung cancer | 2002 (Cycle 11) | $405,795 |
University of California, San Diego | Cancer | |
Internet-enhanced proactive telephone counseling | 2002 (Cycle 11) | $674,731 |
Veterans Medical Research Foundation | Tobacco-Use Prevention and Cessation | |
The geography of tobacco related disease in California | 2002 (Cycle 11) | $374,786 |
Pacific Institute for Research and Evaluation | Epidemiology | |
Nicotine-pathological angiogenesis and genetic determinants | 2002 (Cycle 11) | $608,420 |
Stanford University | Cardiovascular Disease | |
Modeling cost/effectiveness of tobacco control programs | 2002 (Cycle 11) | $129,915 |
University of California, San Diego | Public Health, Public Policy, and Economics | |
Effect of tobacco-related policy change on smoking behavior | 2002 (Cycle 11) | $303,504 |
University of California, San Diego | Public Health, Public Policy, and Economics | |
Nicotinic receptors and Parkinson's disease | 2002 (Cycle 11) | $376,470 |
The Parkinson's Institute | Nicotine Dependence | |
Effect of smoke and gender on bronchiolar injury and repair | 2002 (Cycle 11) | $413,288 |
University of California, Davis | Pulmonary Disease | |
Molecular predictors of oral cancer development | 2002 (Cycle 11) | $419,000 |
University of California, San Francisco | Cancer | |
Modeling cost/effectiveness of tobacco control programs | 2002 (Cycle 11) | $23,238 |
University of California, Los Angeles | Public Health, Public Policy, and Economics | |
Inflammation, innate immunity, TLRs, and atherosclerosis | 2002 (Cycle 11) | $697,650 |
Scripps Research Institute | Cardiovascular Disease | |
Smoking and variation of cardiovascular disease genes | 2002 (Cycle 11) | $635,131 |
Children's Hospital Oakland Research Institute | Epidemiology | |
Nicotinic receptors, smoking and Parkinson's Disease | 2002 (Cycle 11) | $765,971 |
Stanford University | Epidemiology | |
Simple exposure indicators for ETS particles | 2002 (Cycle 11) | $749,647 |
Lawrence Berkeley National Laboratory | General Biomedical Science | |
Prenatal smoke exposure and age at menarche | 2002 (Cycle 11) | $129,090 |
Sequoia Foundation | Epidemiology | |
Brain imaging in nicotine addiction | 2002 (Cycle 11) | $419,881 |
University of California, Los Angeles | Nicotine Dependence | |
Immunopharmacotherapy as a treatment for nicotine addiction | 2002 (Cycle 11) | $515,270 |
Scripps Research Institute | Nicotine Dependence | |
Smoking induced dopamine release: buproprion effects | 2002 (Cycle 11) | $659,060 |
Brentwood Biomedical Research Institute | Nicotine Dependence | |
Cardiac ion channels and tobacco-related disease | 2002 (Cycle 11) | $389,983 |
University of California, Santa Barbara | Cardiovascular Disease | |
Vascular targeting of lung tumors | 2002 (Cycle 11) | $830,563 |
Sidney Kimmel Cancer Center | Cancer | |
p53 and p14ARF: Multiple pathways of lung cancer suppression | 2002 (Cycle 11) | $821,050 |
Sidney Kimmel Cancer Center | Cancer | |
Tobacco prevention/cessation at continuation schools | 2002 (Cycle 11) | $848,679 |
University of Southern California | Tobacco-Use Prevention and Cessation | |
Novel agents for apoptosis of lung cancer | 2002 (Cycle 11) | $787,977 |
The Burnham Institute for Medical Research | Cancer | |
Pager-assisted smoking cessation treatment | 2002 (Cycle 11) | $463,689 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
2001 (Cycle 10)
Effect of tobacco smoke on leucocyte adhesion in vivo | 2001 (Cycle 10) | $1,023,946 |
La Jolla Institute for Molecular Medicine | Pulmonary Disease | |
Self-hypnosis for smoking cessation | 2001 (Cycle 10) | $413,119 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Spanish/English web site for smoking cessation trials | 2001 (Cycle 10) | $519,674 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Cardiovascular responses through spinal nicotinic receptors | 2001 (Cycle 10) | $448,941 |
University of California, San Diego | Nicotine Dependence | |
Model for surveillance of CA tobacco control policies | 2001 (Cycle 10) | $325,761 |
Pacific Institute for Research and Evaluation | Public Health, Public Policy, and Economics | |
Transdermal nicotine for smokers with schizophrenia | 2001 (Cycle 10) | $640,429 |
LA Biomedical Research Institute at Harbor-UCLA Medical Center | Tobacco-Use Prevention and Cessation | |
Smoking and virulence of periodontal pathogens | 2001 (Cycle 10) | $289,574 |
Loma Linda University | General Biomedical Science | |
Patterns of tobacco use from adolescence to young adulthood | 2001 (Cycle 10) | $431,132 |
RAND Corporation | Epidemiology | |
Mechanism of smoke-induced MUC5B gene expression | 2001 (Cycle 10) | $392,117 |
University of California, Davis | Pulmonary Disease | |
Smoking, microsatellite instability & gastric cancers | 2001 (Cycle 10) | $729,199 |
University of Southern California | Epidemiology | |
Anabolic therapies for muscle dysfunction in women with COPD | 2001 (Cycle 10) | $632,153 |
LA Biomedical Research Institute at Harbor-UCLA Medical Center | Pulmonary Disease | |
Smoking and the pathogenesis of macular degeneration | 2001 (Cycle 10) | $316,038 |
University of California, Santa Barbara | General Biomedical Science | |
Clinical pharmacology of tobacco alkaloids | 2001 (Cycle 10) | $373,408 |
University of California, San Francisco | General Biomedical Science | |
Neurobehavioral consequences of adolescent nicotine exposure | 2001 (Cycle 10) | $630,710 |
Scripps Research Institute | Nicotine Dependence | |
Chemokine-based therapy for lung cancer | 2001 (Cycle 10) | $416,940 |
University of California, Los Angeles | Cancer | |
Effects of nicotine withdrawal on aviator performance | 2001 (Cycle 10) | $515,243 |
Stanford University | Nicotine Dependence | |
Adolescent susceptibility to tobacco: a panel analysis | 2001 (Cycle 10) | $495,433 |
University of California, Irvine | Epidemiology | |
Persistent smoking in bars: an ethnographic analysis | 2001 (Cycle 10) | $482,317 |
Pacific Institute for Research and Evaluation | Public Health, Public Policy, and Economics | |
Nicotine withdrawal, smoking & attention: an fMRI study | 2001 (Cycle 10) | $515,303 |
University of California, Los Angeles | Nicotine Dependence | |
Analysis of a lung tumor supressor gene at 3p21.3 | 2001 (Cycle 10) | $249,438 |
Beckman Research Institute of the City of Hope | Cancer | |
Molecular neurobiology of nicotine addiction | 2001 (Cycle 10) | $263,298 |
University of California, Los Angeles | Nicotine Dependence | |
Fertility, smoking and early mammalian development | 2001 (Cycle 10) | $454,490 |
University of California, Riverside | General Biomedical Science | |
Smoking prevention for Asian-American college students | 2001 (Cycle 10) | $588,595 |
Veterans Medical Research Foundation | Epidemiology | |
Neurobiological substrates of nicotine addiction | 2001 (Cycle 10) | $402,852 |
Scripps Research Institute | Nicotine Dependence | |
Novel regulatory mechanisms for lung cancer growth | 2001 (Cycle 10) | $620,032 |
Veterans Medical Research Foundation | Cancer | |
Two approaches to referral for smoking cessation treatment | 2001 (Cycle 10) | $496,836 |
University of California, Los Angeles | Tobacco-Use Prevention and Cessation | |
Mechanisms underlying modulations of respiration by nicotine | 2001 (Cycle 10) | $330,458 |
University of California, Los Angeles | Pulmonary Disease | |
Environmental tobacco smoke exposure & adult asthma | 2001 (Cycle 10) | $460,032 |
University of California, San Francisco | Epidemiology | |
Smoking-induced oxidant stress & platelet integrin alpha.... | 2001 (Cycle 10) | $801,893 |
The Burnham Institute for Medical Research | Cardiovascular Disease | |
Tobacco smoke, inflammation & atherosclerosis | 2001 (Cycle 10) | $754,932 |
Scripps Research Institute | Cardiovascular Disease | |
The role of media in smoking initiation & cessation | 2001 (Cycle 10) | $414,203 |
University of California, San Diego | Public Health, Public Policy, and Economics | |
ApoE isoforms, fatty acid metabolism and atherosclerosis | 2001 (Cycle 10) | $691,616 |
J. David Gladstone Institutes | Cardiovascular Disease | |
Analysis of California adolescent tobacco data | 2001 (Cycle 10) | $475,742 |
University of California, Los Angeles | Epidemiology | |
Bispecific molecular therapy of small cell lung cancer | 2001 (Cycle 10) | $434,805 |
University of California, San Diego | Cancer | |
Dysregulation of VSMC signaling induced by nicotine | 2001 (Cycle 10) | $683,510 |
Stanford University | Cardiovascular Disease | |
2000 (Cycle 9)
Neurobehavioral consequences of adolescent nicotine exposure | 2000 (Cycle 9) | $120,000 |
Scripps Research Institute | Nicotine Dependence | |
Stress and the use of nicotine | 2000 (Cycle 9) | $897,484 |
Cedars-Sinai Medical Center | Nicotine Dependence | |
Hyperactive nicotine receptors | 2000 (Cycle 9) | $1,138,225 |
California Institute of Technology | Nicotine Dependence | |
Proteins involved in nicotine receptor clustering | 2000 (Cycle 9) | $307,246 |
University of California, San Diego | Nicotine Dependence | |
Effects of prenatal nicotine exposure on nicotinic receptors | 2000 (Cycle 9) | $471,654 |
University of California, San Francisco | Nicotine Dependence | |
Macrophage function in atherosclerosis | 2000 (Cycle 9) | $709,200 |
Scripps Research Institute | Cardiovascular Disease | |
Post-isoprenylation processing steps as anticancer targets | 2000 (Cycle 9) | $1,017,450 |
J. David Gladstone Institutes | Cancer | |
Effect of maternal smoking on human placental development | 2000 (Cycle 9) | $515,124 |
University of California, San Francisco | General Biomedical Science | |
Cytokine gene-modified dendritic cells for lung cancer | 2000 (Cycle 9) | $590,523 |
University of California, Los Angeles | Cancer | |
RCT of tobacco dependence treatment benefits in an HMO & PPO | 2000 (Cycle 9) | $582,472 |
University of California, Berkeley | Public Health, Public Policy, and Economics | |
Improved therapy of lung cancer | 2000 (Cycle 9) | $668,814 |
California Pacific Medical Center Research Institute | Cancer | |
Human neurophysiology of nicotine analgesia: sex differences | 2000 (Cycle 9) | $595,994 |
University of California, San Francisco | Nicotine Dependence | |
Novel nicotine cessation therapeutics | 2000 (Cycle 9) | $802,840 |
Human BioMolecular Research Institute | Nicotine Dependence | |
Chronic bronchitis: pathology of mucin gene expression | 2000 (Cycle 9) | $147,758 |
University of California, San Francisco | Pulmonary Disease | |
Tobacco industry targeting of African Americans | 2000 (Cycle 9) | $99,680 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Experimental evaluation of minors' access to tobacco | 2000 (Cycle 9) | $655,347 |
San Diego State University Research Foundation | Public Health, Public Policy, and Economics | |
Predicting progress toward cessation in California smokers | 2000 (Cycle 9) | $99,954 |
University of California, San Diego | Public Health, Public Policy, and Economics | |
Novel regulatory mechanisms for lung cancer growth | 2000 (Cycle 9) | $100,000 |
University of California, San Diego | Cancer | |
DNA replication, regulation of the cell cycle, and cancer | 2000 (Cycle 9) | $571,742 |
California Institute of Technology | General Biomedical Science | |
Nicotinic and Schizophrenia | 2000 (Cycle 9) | $87,719 |
University of California, Irvine | Nicotine Dependence | |
Implementation of tobacco programs in California schools | 2000 (Cycle 9) | $765,192 |
University of Southern California | Public Health, Public Policy, and Economics | |
A dynamic model of smoking and healthcare expenditures in CA | 2000 (Cycle 9) | $595,843 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
The role of media in smoking initiation & cessation | 2000 (Cycle 9) | $98,395 |
University of California, San Diego | Public Health, Public Policy, and Economics | |
Chronic bronchitis: pathology of mucin gene expression | 2000 (Cycle 9) | $329,481 |
University of California, Davis | Pulmonary Disease | |
Tobacco use & acculturation: CA residents of Korean descent | 2000 (Cycle 9) | $825,701 |
San Diego State University Research Foundation | Epidemiology | |
Pathophysiology of abnormal remnant metabolism in smokers | 2000 (Cycle 9) | $783,345 |
Palo Alto Medical Foundation Research Institute | Cardiovascular Disease | |
Role of Smad protein in growth inhibition of tumor cells | 2000 (Cycle 9) | $474,492 |
Lawrence Berkeley National Laboratory | Cancer | |
Comprehensive evaluation of the ischemic leg | 2000 (Cycle 9) | $672,390 |
Stanford University | General Biomedical Science | |
Lung volume reduction surgery in an animal emphysema model | 2000 (Cycle 9) | $456,336 |
University of California, Irvine | Pulmonary Disease | |
Mobilized dendritic cells for lung cancer | 2000 (Cycle 9) | $950,821 |
Stanford University | Cancer | |
Studies of novel antitumor agents for lung carcinoma | 2000 (Cycle 9) | $833,491 |
University of California, San Diego | Cancer | |
Molecular origins of apoB atherogenic lipoproteins | 2000 (Cycle 9) | $445,617 |
University of California, San Francisco | Cardiovascular Disease | |
Behavioral effects of neonatal nicotine exposure | 2000 (Cycle 9) | $624,780 |
San Diego State University Research Foundation | Nicotine Dependence | |
Determinants of smoking among gay & lesbian youth | 2000 (Cycle 9) | $509,771 |
University of California, San Francisco | Epidemiology | |
Dissuading at-risk youth from smoking via mass media | 2000 (Cycle 9) | $610,340 |
University of California, Irvine | Tobacco-Use Prevention and Cessation | |
Use of existing data to develop new tobacco control strategies | 2000 (Cycle 9) | $402,610 |
University of California, San Diego | Public Health, Public Policy, and Economics | |
Role of integrins in cardiac innervation and function | 2000 (Cycle 9) | $293,277 |
University of California, Santa Barbara | Cardiovascular Disease | |
Tests of the tobacco industry's youth smoking prevention ads | 2000 (Cycle 9) | $343,044 |
Stanford University | Public Health, Public Policy, and Economics | |
Mechanism of nicotine action in developing lung | 2000 (Cycle 9) | $720,281 |
University of Southern California | Pulmonary Disease | |
Tobacco exposure & subclinical atherosclerosis in NIDDM | 2000 (Cycle 9) | $321,363 |
University of Southern California | Epidemiology | |
Smoking, estrogen metabolites & cognitive function | 2000 (Cycle 9) | $193,049 |
University of California, San Diego | Epidemiology | |
CT imaging to assist diagnosis of solitary pulmonary nodules | 2000 (Cycle 9) | $59,002 |
University of California, Los Angeles | Cancer | |
ETS effects on breathing patterns | 2000 (Cycle 9) | $590,780 |
University of California, Davis | Pulmonary Disease | |
Recruitment of leucocytes to atherosclerotic lesions in vivo | 2000 (Cycle 9) | $175,102 |
University of California, San Diego | Cardiovascular Disease | |
Nicotine & cardiac vulnerability to fibrillation | 2000 (Cycle 9) | $120,000 |
Cedars-Sinai Medical Center | Cardiovascular Disease | |
Proposition 99 Archives | 2000 (Cycle 9) | $100,000 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Analysis of a candidate lung tumor suppressor gene at 3p21.3 | 2000 (Cycle 9) | $111,910 |
Beckman Research Institute of the City of Hope | Cancer | |
Smoking & the pathogenesis of macular degeneration | 2000 (Cycle 9) | $99,500 |
University of California, Santa Barbara | General Biomedical Science | |
Nicotine regulates cardiac toxicity with lipopolysaccharide | 2000 (Cycle 9) | $100,000 |
University of California, San Diego | Cardiovascular Disease | |
Novel DNA vaccines for the treatment of lung cancer | 2000 (Cycle 9) | $1,063,300 |
Scripps Research Institute | Cancer | |
Telephone counseling for smokers using pharmacotherapy | 2000 (Cycle 9) | $774,971 |
University of California, San Diego | Tobacco-Use Prevention and Cessation | |
Nicotine in the Brain | 2000 (Cycle 9) | $518,966 |
University of California, San Diego | Nicotine Dependence | |
Analysis of tobacco industry documents on scientific research | 2000 (Cycle 9) | $442,646 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Human tryptase gene expression: role in COPD | 2000 (Cycle 9) | $545,409 |
University of California, San Francisco | Pulmonary Disease | |
Nicotine effects on renal function in experimental diabetes | 2000 (Cycle 9) | $98,313 |
University of California, San Diego | Cardiovascular Disease | |
1999 (Cycle 8)
Detection of occult metastases in patients with lung cancer | 1999 (Cycle 8) | $723,842 |
University of Southern California | Cancer | |
Effects of passive smoking and pregnancy | 1999 (Cycle 8) | $565,186 |
Lawrence Livermore National Laboratory | Cancer | |
Dissemination of a smoking cessation program for in patients | 1999 (Cycle 8) | $710,621 |
Stanford University | Tobacco-Use Prevention and Cessation | |
Explaining racial differences in smoking | 1999 (Cycle 8) | $151,430 |
San Diego State University Research Foundation | Public Health, Public Policy, and Economics | |
Effect of tobacco related policy change on smoking behavior | 1999 (Cycle 8) | $261,672 |
University of California, San Diego | Public Health, Public Policy, and Economics | |
Parkinson's Disease: A Protective Effect of Smoking? | 1999 (Cycle 8) | $512,849 |
Stanford University | Epidemiology | |
Ethnic difference in cigarette smoking dynamics among youth | 1999 (Cycle 8) | $366,852 |
University of Southern California | Epidemiology | |
Tobacco Control Digital Library | 1999 (Cycle 8) | $514,796 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Neurotransmitter systems and tobacco smoking | 1999 (Cycle 8) | $430,910 |
University of California, Los Angeles | Nicotine Dependence | |
Neurotoxic effects of nicotine: anatomy, mechanisms, effects | 1999 (Cycle 8) | $183,424 |
University of California, Los Angeles | Nicotine Dependence | |
Evaluation of office ETS exposure in relation to AB 13 | 1999 (Cycle 8) | $242,063 |
Public Health Institute | Public Health, Public Policy, and Economics | |
Evaluation of office ETS exposure in relation to AB13 | 1999 (Cycle 8) | $208,554 |
Lawrence Berkeley National Laboratory | General Biomedical Science | |
Role of protein phosphatase 2A in lung cancer | 1999 (Cycle 8) | $307,522 |
University of California, San Diego | Cancer | |
African Americans and Mentholated Cigarettes | 1999 (Cycle 8) | $417,968 |
Charles R. Drew University of Medicine & Science | Nicotine Dependence | |
Explaining racial differences in smoking | 1999 (Cycle 8) | $149,280 |
Public Health Foundation Enterprises, Inc. | Public Health, Public Policy, and Economics | |
Smoking, breast cancer and tobacco metabolizing genes | 1999 (Cycle 8) | $120,000 |
Childrens Hospital, Los Angeles | Epidemiology | |
Supplement to tobacco disease in twins | 1999 (Cycle 8) | $432,989 |
University of Southern California | Epidemiology | |
Smoking Control Policies in California Health Plans | 1999 (Cycle 8) | $80,542 |
University of California, Berkeley | Public Health, Public Policy, and Economics | |
Effectiveness of two different regimens in smoking clinic | 1999 (Cycle 8) | $272,989 |
University of California, Los Angeles | Nicotine Dependence | |
Nicotine May Affect Inflammation | 1999 (Cycle 8) | $435,425 |
University of California, San Francisco | Nicotine Dependence | |
Tobacco oxidants and the ceramide path in lung cell death | 1999 (Cycle 8) | $427,613 |
University of California, Davis | Pulmonary Disease | |
Novel strategy for protecting neurons from injury in stroke | 1999 (Cycle 8) | $742,809 |
Stanford University | Cardiovascular Disease | |
Vascular targeting of lung tumors | 1999 (Cycle 8) | $899,686 |
Sidney Kimmel Cancer Center | Cancer | |
Telephone Counseling for Pregnant Smokers | 1999 (Cycle 8) | $828,931 |
University of California, San Diego | Tobacco-Use Prevention and Cessation | |
A longitudinal study of smoking transitions in youth | 1999 (Cycle 8) | $577,574 |
University of California, San Diego | Tobacco-Use Prevention and Cessation | |
Smoking during pregnancy: chromosome damage in newborns | 1999 (Cycle 8) | $1,662,871 |
Lawrence Livermore National Laboratory | Epidemiology | |
Ascertainment of environmental tobacco exposure in pregnancy | 1999 (Cycle 8) | $2,053,747 |
Sequoia Foundation | Epidemiology | |
Economic Analysis of Smoking Cessation Therapies | 1999 (Cycle 8) | $270,206 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Role of nicotine in neuro protection | 1999 (Cycle 8) | $722,263 |
The Parkinson's Institute | Nicotine Dependence | |
Nicotine effects on neurological development | 1999 (Cycle 8) | $189,233 |
University of California, Irvine | Nicotine Dependence | |
Environmental tobacco smoke effects on lung surfactant | 1999 (Cycle 8) | $423,216 |
University of California, Santa Barbara | Pulmonary Disease | |
Apolipoprotein E: remnant metabolism and atherogenesis | 1999 (Cycle 8) | $793,474 |
J. David Gladstone Institutes | Cardiovascular Disease | |
1998 (Cycle 7)
Smoking and lifestyle risk factors for premenstrual changes | 1998 (Cycle 7) | $297,783 |
University of California, Davis | Epidemiology | |
Studies of novel antitumor agents for lung cancers | 1998 (Cycle 7) | $306,000 |
University of California, San Diego | Cancer | |
Vapor-phase organics in ETS: dynamics and exposure | 1998 (Cycle 7) | $722,775 |
Lawrence Berkeley National Laboratory | General Biomedical Science | |
Keep me smokefree | 1998 (Cycle 7) | $550,002 |
Education Training and Research Associates, Inc. | Tobacco-Use Prevention and Cessation | |
Mechanism of stress effects on weight in nicotine withdrawal | 1998 (Cycle 7) | $407,019 |
University of California, San Francisco | Nicotine Dependence | |
Spanish/English web site for smoking cessation trials | 1998 (Cycle 7) | $450,400 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Smoke-free bars: analysis of the response from Long Beach | 1998 (Cycle 7) | $552,978 |
California State University, Long Beach Foundation | Public Health, Public Policy, and Economics | |
Developing new vaccines for lung cancer | 1998 (Cycle 7) | $398,511 |
University of California, Los Angeles | Cancer | |
Nitrogen Oxides and cigarette smoke-induced injury | 1998 (Cycle 7) | $304,118 |
University of California, Davis | Pulmonary Disease | |
Bupropion for smoking cessation | 1998 (Cycle 7) | $471,154 |
University of California, San Francisco | Nicotine Dependence | |
Vitamin E kinetics in smokers | 1998 (Cycle 7) | $332,110 |
University of California, Davis | General Biomedical Science | |
Transport and disposition of nicotine in the human placenta | 1998 (Cycle 7) | $333,108 |
University of California, San Francisco | General Biomedical Science | |
Role of thioredoxin in ETS-induced pulmonary airway injury | 1998 (Cycle 7) | $425,665 |
University of California, Davis | Pulmonary Disease | |
The effect of tobacco smoke on immune function in twins | 1998 (Cycle 7) | $822,641 |
University of Southern California | Epidemiology | |
Role of nicotine/nicotinic receptors in Parkinson's disease | 1998 (Cycle 7) | $644,770 |
The Parkinson's Institute | Nicotine Dependence | |
Effects of tobacco smoke exposure on hormones and fertility | 1998 (Cycle 7) | $115,335 |
Sequoia Foundation | Epidemiology | |
Effects of nicotine on postinfarction cardiac remodeling | 1998 (Cycle 7) | $459,799 |
University of California, San Diego | Cardiovascular Disease | |
Will apoE cause regression of atherosclerotic lesions? | 1998 (Cycle 7) | $165,299 |
J. David Gladstone Institutes | Cardiovascular Disease | |
Clinical pharmacology of tobacco alkaloids | 1998 (Cycle 7) | $439,882 |
University of California, San Francisco | Nicotine Dependence | |
Inflammatory compounds:role in tobacco-related lung disease | 1998 (Cycle 7) | $447,367 |
University of California, San Diego | Cancer | |
Maternal DNA repair of tobacco-induced sperm lesions | 1998 (Cycle 7) | $1,046,880 |
Lawrence Livermore National Laboratory | General Biomedical Science | |
Genetic susceptibility to tobacco-induced lung cancer | 1998 (Cycle 7) | $406,120 |
University of California, Los Angeles | Cancer | |
Effect of tobacco smoke on leukocyte adhesion in vivo | 1998 (Cycle 7) | $754,361 |
La Jolla Institute for Molecular Medicine | Pulmonary Disease | |
Programmed cell death in cigarette-induced lung disease | 1998 (Cycle 7) | $371,556 |
University of California, San Francisco | Pulmonary Disease | |
Implementation of California AB 13: smoking ban in bars | 1998 (Cycle 7) | $315,181 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Carbon monoxide and the brain growth spurt | 1998 (Cycle 7) | $464,268 |
University of California, Los Angeles | General Biomedical Science | |
Tobacco use and cessation among drug users | 1998 (Cycle 7) | $249,392 |
University of California, Los Angeles | Epidemiology | |
Lipoprotein classes and susceptibility to atherosclerosis | 1998 (Cycle 7) | $702,940 |
J. David Gladstone Institutes | Cardiovascular Disease | |
Reducing provision of tobacco to minors from social sources | 1998 (Cycle 7) | $639,838 |
Stanford University | Tobacco-Use Prevention and Cessation | |
ETS exposures in the California Teachers Study cohort | 1998 (Cycle 7) | $449,677 |
Public Health Institute | Epidemiology | |
Determining how cholesterol-rich Lp(a) causes heart disease | 1998 (Cycle 7) | $797,092 |
J. David Gladstone Institutes | Cardiovascular Disease | |
Effect of tobacco smoke on lung airway surface liquid | 1998 (Cycle 7) | $115,658 |
Children's Hospital Oakland Research Institute | Pulmonary Disease | |
ETS Effects on airway development in the primate lung | 1998 (Cycle 7) | $483,652 |
University of California, Davis | General Biomedical Science | |
Role of passive smoke on sperm, ICSI and IVF | 1998 (Cycle 7) | $628,862 |
University of California, San Diego | Epidemiology | |
Effects of environmental tobacco smoke on pulmonary allergy | 1998 (Cycle 7) | $282,568 |
University of California, Davis | Pulmonary Disease | |
Neurobiological substrates of nicotine addiction | 1998 (Cycle 7) | $742,393 |
Scripps Research Institute | Nicotine Dependence | |
Hormone replacement therapy, smoking & lipoprotein oxidation | 1998 (Cycle 7) | $385,808 |
Scripps Research Institute | Cardiovascular Disease | |
Effects of Selegiline on craving for nicotine | 1998 (Cycle 7) | $100,450 |
Stanford University | Nicotine Dependence | |
Hormone replacement therapy, smoking & lipoprotein oxidation | 1998 (Cycle 7) | $245,584 |
La Jolla Institute for Molecular Medicine | Cardiovascular Disease | |
Effects of environmental tobacco smoke on the artery wall | 1998 (Cycle 7) | $449,673 |
University of California, Davis | Cardiovascular Disease | |
An athletic trainer mediated spit tobacco cessation program | 1998 (Cycle 7) | $490,546 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Natural history of tobacco addiction in adolescents | 1998 (Cycle 7) | $499,505 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Family factors in smoking acquisition among Latino youth | 1998 (Cycle 7) | $865,636 |
San Diego State University Research Foundation | Tobacco-Use Prevention and Cessation | |
Oxidative damage to sperm DNA: smoking and diet interaction | 1998 (Cycle 7) | $155,135 |
University of California, Berkeley | General Biomedical Science | |
Antioxidants, cigarette smoking and atherosclerosis | 1998 (Cycle 7) | $730,640 |
University of Southern California | Epidemiology | |
Mechanisms underlying diaphragm adaptations in emphysema | 1998 (Cycle 7) | $642,624 |
Cedars-Sinai Medical Center | Pulmonary Disease | |
Suppressor genes of lung cancer | 1998 (Cycle 7) | $859,254 |
The Burnham Institute for Medical Research | Cancer | |
How does smoke activate mucin transcription in lung cells? | 1998 (Cycle 7) | $432,415 |
University of California, San Francisco | Pulmonary Disease | |
Smoking treatment for substance abusing adolescents | 1998 (Cycle 7) | $431,607 |
University of California, San Diego | Tobacco-Use Prevention and Cessation | |
Towards gene therapy for tobacco-related vascular disease | 1998 (Cycle 7) | $719,328 |
J. David Gladstone Institutes | Cardiovascular Disease | |
Mechanisms by which tobacco accelerates atherosclerosis | 1998 (Cycle 7) | $675,731 |
Stanford University | Cardiovascular Disease | |
Oxidative damage to sperm DNA: smoking and diet interaction | 1998 (Cycle 7) | $132,367 |
Children's Hospital Oakland Research Institute | General Biomedical Science | |
Therapy for muscle dysfunction in COPD: cellular adaptations | 1998 (Cycle 7) | $502,904 |
Cedars-Sinai Medical Center | Pulmonary Disease | |
Behavioral epidemiology of tobacco use among gay men | 1998 (Cycle 7) | $626,433 |
University of California, San Francisco | Epidemiology | |
1997 (Cycle 6)
Environmental tobacco smoke and early atherosclerosis | 1997 (Cycle 6) | $383,814 |
University of Southern California | Epidemiology | |
Cigar smoking among young adults: formative research | 1997 (Cycle 6) | $292,920 |
California State University, Long Beach Foundation | Tobacco-Use Prevention and Cessation | |
Gene therapy for emphysema | 1997 (Cycle 6) | $443,179 |
University of California, San Francisco | Pulmonary Disease | |
Serum cotinine levels and reproductive outcomes | 1997 (Cycle 6) | $452,159 |
Public Health Institute | Epidemiology | |
Reducing minors' access to tobacco: project CHALK | 1997 (Cycle 6) | $398,114 |
Public Health Foundation Enterprises, Inc. | Tobacco-Use Prevention and Cessation | |
Nicotonic receptors: role in addiction and reproduction | 1997 (Cycle 6) | $437,480 |
Salk Institute for Biological Studies | Nicotine Dependence | |
Pediatrician training to prevent children's tobacco exposure | 1997 (Cycle 6) | $133,852 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Anti-Tobacco Programming: Reaching Deaf and Hard of Hearing | 1997 (Cycle 6) | $446,947 |
University of California, Los Angeles | Tobacco-Use Prevention and Cessation | |
How does cigarette smoke induce cancer? | 1997 (Cycle 6) | $811,518 |
Beckman Research Institute of the City of Hope | Cancer | |
Fertility, smoking and early mammalian development | 1997 (Cycle 6) | $452,243 |
University of California, Riverside | General Biomedical Science | |
Environmental tobacco smoke and newborn lung development | 1997 (Cycle 6) | $440,500 |
University of California, Davis | General Biomedical Science | |
Developing policy to reverse cigar trend: roles of media | 1997 (Cycle 6) | $249,785 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Effect of maternal smoking on human placental development | 1997 (Cycle 6) | $450,000 |
University of California, San Francisco | General Biomedical Science | |
Nicotine and cardiac vulnerability to fibrillation | 1997 (Cycle 6) | $370,057 |
Cedars-Sinai Medical Center | Cardiovascular Disease | |
Patterns of tobacco use from adolescence to young adulthood | 1997 (Cycle 6) | $565,277 |
RAND Corporation | Epidemiology | |
Cigarette smoke alters lipoprotein & artery wall interaction | 1997 (Cycle 6) | $472,876 |
University of California, Los Angeles | Cardiovascular Disease | |
Tobacco-related cancer prevention by Vitamin A derivatives | 1997 (Cycle 6) | $274,488 |
SRI International | Cancer | |
Motivation-enhanced teenage tobacco use cessation | 1997 (Cycle 6) | $750,248 |
University of Southern California | Tobacco-Use Prevention and Cessation | |
Aggression and Nicotine | 1997 (Cycle 6) | $230,826 |
University of California, Irvine | Nicotine Dependence | |
The role of multiple genes in susceptibility to smoking | 1997 (Cycle 6) | $557,829 |
Beckman Research Institute of the City of Hope | Epidemiology | |
Recruitment of leukocytes to atherosclerotic lesions in vivo | 1997 (Cycle 6) | $352,405 |
University of California, San Diego | Cardiovascular Disease | |
Brain adaptations to chronic nicotine expsoure | 1997 (Cycle 6) | $402,111 |
University of California, Irvine | Nicotine Dependence | |
Spanish tobacco-related disease self-management: evaluation | 1997 (Cycle 6) | $693,751 |
Stanford University | Tobacco-Use Prevention and Cessation | |
Novel imaging methods for diagnosing tobacco related cancers | 1997 (Cycle 6) | $629,087 |
Stanford University | Cancer | |
Nicotine pharmacogenetics: influence of ethnicity | 1997 (Cycle 6) | $366,244 |
LA Biomedical Research Institute at Harbor-UCLA Medical Center | Nicotine Dependence | |
Brachial Vasoreactivity in Young Adult Smokers | 1997 (Cycle 6) | $332,294 |
Osteoporosis Medical Center | Epidemiology | |
Smoking initiation among Chinese and Vietnames adolescents | 1997 (Cycle 6) | $449,734 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Hyperactive nicotine receptors | 1997 (Cycle 6) | $486,158 |
California Institute of Technology | Nicotine Dependence | |
Oral clefts, smoking & variation toxin biotransformation | 1997 (Cycle 6) | $677,128 |
Children's Hospital Oakland Research Institute | Epidemiology | |
Evaluation of ad strategies for preventing youth tobacco use | 1997 (Cycle 6) | $136,953 |
University of California, Irvine | Public Health, Public Policy, and Economics | |
Secondhand smoke promotes chemical toxicity in fetal lung | 1997 (Cycle 6) | $190,536 |
University of California, Davis | General Biomedical Science | |
Case studies of indoor air regulations: role of research | 1997 (Cycle 6) | $292,210 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Novel therapy for pancreatic cancer | 1997 (Cycle 6) | $452,332 |
University of California, Irvine | Cancer | |
Cardiovascular responses to nicotine | 1997 (Cycle 6) | $430,843 |
University of California, San Diego | Nicotine Dependence | |
Irritant and pain-reducing effects of nicotine | 1997 (Cycle 6) | $415,704 |
University of California, Davis | Nicotine Dependence | |
Transdermal nicotine replacement for hospitalized smokers | 1997 (Cycle 6) | $451,969 |
University of California, San Francisco | Nicotine Dependence | |
Smokeless tobacco cessation among lumber mill employees | 1997 (Cycle 6) | $620,213 |
University of Southern California | Tobacco-Use Prevention and Cessation | |
Does nicotine inhibit anticancer activities of Vitamin A? | 1997 (Cycle 6) | $788,808 |
The Burnham Institute for Medical Research | Cancer | |
Nicotine pharmacogenetics: influence of ethnicity | 1997 (Cycle 6) | $242,344 |
Cedars-Sinai Medical Center | Nicotine Dependence | |
Diaphragm adaptations following treatment for emphysema | 1997 (Cycle 6) | $469,400 |
Cedars-Sinai Medical Center | Pulmonary Disease | |
Development of a blood test for pancreatic cancer | 1997 (Cycle 6) | $308,819 |
Stanford University | Cancer | |
Quantification of population exposure to secondhand smoke | 1997 (Cycle 6) | $686,858 |
Stanford University | Epidemiology | |
Smoking predictors in Mexican American youth | 1997 (Cycle 6) | $534,603 |
University of San Francisco | Tobacco-Use Prevention and Cessation | |
The role of nicotine receptors in nicotine dependence | 1997 (Cycle 6) | $381,317 |
University of California, Irvine | Nicotine Dependence | |
Improving tobacco use assessment among youth via telephone | 1997 (Cycle 6) | $347,440 |
University of California, Berkeley | Public Health, Public Policy, and Economics | |
Quantification of lung doses from inhaled tobacco smoke | 1997 (Cycle 6) | $425,728 |
University of California, Irvine | General Biomedical Science | |
Nicotine toxicity acting on cardiac neurons | 1997 (Cycle 6) | $446,920 |
University of California, San Diego | Nicotine Dependence | |
Therapies of muscle dysfunction in obstructive lung disease | 1997 (Cycle 6) | $659,714 |
LA Biomedical Research Institute at Harbor-UCLA Medical Center | Pulmonary Disease | |
NRT and paroxetine for smoking cessation | 1997 (Cycle 6) | $646,916 |
Stanford University | Nicotine Dependence | |
Tobacco-related disease in native California twins | 1997 (Cycle 6) | $889,746 |
University of Southern California | Epidemiology | |
Developing treatments that lower blood cholesterol levels | 1997 (Cycle 6) | $746,536 |
Scripps Research Institute | Cardiovascular Disease | |
Indoor measurements of environmental tobacco smoke | 1997 (Cycle 6) | $634,217 |
Lawrence Berkeley National Laboratory | General Biomedical Science | |
ETS effects on pulmonary breathing patterns | 1997 (Cycle 6) | $446,954 |
University of California, Davis | Pulmonary Disease | |
The role of media in smoking initiation and cessation | 1997 (Cycle 6) | $433,880 |
University of California, San Diego | Epidemiology | |
Preventing tobacco smoke diseases by network antioxidants | 1997 (Cycle 6) | $388,714 |
University of California, Berkeley | General Biomedical Science | |
Tobacco-related cancer prevention by Vitamin A derivatives | 1997 (Cycle 6) | $149,947 |
Molecular Medicine Research Institute | Cancer | |
School tobacco program and policy trial | 1997 (Cycle 6) | $1,162,877 |
University of Southern California | Tobacco-Use Prevention and Cessation | |
Lung volume reduction surgery in an emphysema model | 1997 (Cycle 6) | $404,139 |
University of California, Irvine | Pulmonary Disease | |
1995 (Cycle 4)
Fertility, Smoking, and Early Mammalian Development | 1995 (Cycle 4) | $321,193 |
University of California, Riverside | General Biomedical Science | |
Inheritance and Smoking in Urinary Tract & Pancreas Cancer | 1995 (Cycle 4) | $248,283 |
University of Southern California | Epidemiology | |
Determinants of Susceptibility to Oxidized Lipoproteins | 1995 (Cycle 4) | $495,384 |
University of California, Los Angeles | Cardiovascular Disease | |
Expression of the Human apo-B Gene in Transgenic Mice | 1995 (Cycle 4) | $211,090 |
J. David Gladstone Institutes | Cardiovascular Disease | |
Role of Ah Receptor Nuclear Translocator in Carcinogenesis | 1995 (Cycle 4) | $140,096 |
University of California, Los Angeles | Cancer | |
Detrimental Influence of Nitric Oxide on Vascular Function | 1995 (Cycle 4) | $8,965 |
University of California, Los Angeles | Cardiovascular Disease | |
Smoking, Free Radicals, Antioxidants and Disease Prevention | 1995 (Cycle 4) | $408,853 |
University of California, Berkeley | Pulmonary Disease | |
Passive Smoking: Role of Airways Reactivity in Infancy | 1995 (Cycle 4) | $486,888 |
University of California, Berkeley | Epidemiology | |
Clinical Pharmacology of Tobacco Alkaloids | 1995 (Cycle 4) | $393,855 |
University of California, San Francisco | General Biomedical Science | |
Electrophysiological Effects of Perinatal Nicotine Exposure | 1995 (Cycle 4) | $293,752 |
San Diego State University Research Foundation | General Biomedical Science | |
Proteins that Remove Atherogeneic Lipoproteins from Blood | 1995 (Cycle 4) | $678,254 |
J. David Gladstone Institutes | Cardiovascular Disease | |
Function and Regulation of the Retinoblastoma Protein | 1995 (Cycle 4) | $385,031 |
University of California, San Diego | Cancer | |
Calorigenic and Atherogenic Effects of Smoking and Nicotine | 1995 (Cycle 4) | $357,492 |
University of California, San Francisco | Cardiovascular Disease | |
Passive Smoking and Clara Cell Development in the Lungs | 1995 (Cycle 4) | $442,317 |
University of California, Davis | Pulmonary Disease | |
Roles of Hypoxia, Nicotine, & Camp in Ischemic Heart Failure | 1995 (Cycle 4) | $746,727 |
SRI International | Cardiovascular Disease | |
NMR Study of 13C Edatrexate Metabolism | 1995 (Cycle 4) | $258,990 |
University of California, Davis | Cancer | |
The Dopamine D2 Receptor in Nicotine Addiction | 1995 (Cycle 4) | $304,790 |
City of Hope National Medical Center | General Biomedical Science | |
Predicting and Reducing Cigarette Sales to Minors | 1995 (Cycle 4) | $350,549 |
Public Health Foundation Enterprises, Inc. | Public Health, Public Policy, and Economics | |
Control of Mucociliary Clearance in the Respiratory Tract | 1995 (Cycle 4) | $276,780 |
University of California, Los Angeles | Pulmonary Disease | |
Interactions of Moesin during platelet activation | 1995 (Cycle 4) | $428,524 |
Stanford University | Cardiovascular Disease | |
Tumor-Specific Vascular Proteins in Lung Cancer | 1995 (Cycle 4) | $105,294 |
University of California, San Diego | Cancer | |
Cellular Defects in Lung caused by Tobacco Smoke | 1995 (Cycle 4) | $319,013 |
University of California, San Francisco | Pulmonary Disease | |
Smoking, Nicotine, Sleep & Mood in Normals & Depression | 1995 (Cycle 4) | $207,434 |
University of California, San Diego | Tobacco-Use Prevention and Cessation | |
Reduction of Passive Smoking in Asthmatic Children | 1995 (Cycle 4) | $282,971 |
San Diego State University Research Foundation | Tobacco-Use Prevention and Cessation | |
Quality of Tobacco Industry Funded Research | 1995 (Cycle 4) | $152,885 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Effect of Smoking on Success Rate of In Vitro Fertilization | 1995 (Cycle 4) | $449,805 |
University of California, San Diego | Epidemiology | |
Expressing & Cloning of ATP-Sensitive Potassium Channels | 1995 (Cycle 4) | $286,163 |
University of California, Santa Barbara | Cardiovascular Disease | |
Structure-Function Correlations for Ras p21 and its Mutants | 1995 (Cycle 4) | $322,049 |
University of Southern California | Cancer | |
Electrophysiological Effects of Perinatal Nicotine Exposure | 1995 (Cycle 4) | $446,225 |
Scripps Research Institute | General Biomedical Science | |
Developmental Relationship between NK and T-Cell Lineages | 1995 (Cycle 4) | $434,126 |
California Institute of Technology | Cancer | |
Smoking, Personality and the Risk of Parkinson's Disease | 1995 (Cycle 4) | $297,245 |
Kaiser Foundation Research Institute | Epidemiology | |
SAR Studies of Novel antitumor Agents for Lung Carcinomas | 1995 (Cycle 4) | $403,338 |
University of California, San Diego | Cancer | |
Effects of Tobacco Smoke on Mucin Production in Rat Airways | 1995 (Cycle 4) | $356,400 |
University of California, San Francisco | Pulmonary Disease | |
Nicotine and Smoking Effects on Neuromuscular Development | 1995 (Cycle 4) | $412,639 |
Cedars-Sinai Medical Center | Pulmonary Disease | |
Gene Markers for Hypertension | 1995 (Cycle 4) | $356,151 |
University of California, San Francisco | Cardiovascular Disease | |
Ad and Movie Imagery and Teen's Perceptions About Smokers | 1995 (Cycle 4) | $190,616 |
University of California, Irvine | Public Health, Public Policy, and Economics | |
Predicting and Reducing Cigarette Sales to Minors | 1995 (Cycle 4) | $358,643 |
University of Southern California | Public Health, Public Policy, and Economics | |
Benzo[a]pyrene: Biogenetic Effects on Hepatocytes in Vitro | 1995 (Cycle 4) | $321,199 |
University of California, San Diego | Cancer | |
Expression of the Human apo-B Gene in Transgenic Mice | 1995 (Cycle 4) | $569,759 |
Palo Alto Medical Foundation Research Institute | Cardiovascular Disease | |
H-Ras Ribozyme Mediated Tumor Suppression of BUX Cells | 1995 (Cycle 4) | $352,183 |
City of Hope National Medical Center | Cancer | |
Cardiac Arrythmias Before and After Smoking Cessation | 1995 (Cycle 4) | $93,780 |
University of California, San Francisco | Cardiovascular Disease | |
A Smokeless Tobacco Cessation Program: High School Athletes | 1995 (Cycle 4) | $533,923 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Effects of Environmental Tobacco Smoke on Pulmonary Allergy | 1995 (Cycle 4) | $256,805 |
University of California, Davis | Pulmonary Disease | |
Transcriptional Regulation of Programmed Cell Dealth | 1995 (Cycle 4) | $304,418 |
University of California, Berkeley | Cancer | |
Heterologous Expression of Brain Nicotinic Acetylcholine Receptor | 1995 (Cycle 4) | $598,774 |
California Institute of Technology | Nicotine Dependence | |
Suppression of Oncogenic Ras Mutations | 1995 (Cycle 4) | $348,032 |
University of California, Berkeley | Cancer | |
A Methodological Multi-Ethnic Study of Smoking Initiation | 1995 (Cycle 4) | $260,978 |
University of California, Los Angeles | Tobacco-Use Prevention and Cessation | |
Hemoglobin Conversion to Pro-Oxidants by Cigarette Smoke | 1995 (Cycle 4) | $454,365 |
Lawrence Berkeley National Laboratory | Cardiovascular Disease | |
Membrane Signaling Pathways of RAS/RAB Proteins | 1995 (Cycle 4) | $574,559 |
Scripps Research Institute | Cancer | |
Identification on Tumors of Molecular Targets for NK Cells | 1995 (Cycle 4) | $314,006 |
University of California, San Francisco | Cancer | |
Effect of Tobacco on Rat Lung Alveolar Lining Liquid | 1995 (Cycle 4) | $643,213 |
Lawrence Berkeley National Laboratory | Pulmonary Disease | |
Vasoactive Mediators of Fetal Growth Retardation | 1995 (Cycle 4) | $615,296 |
Cedars-Sinai Medical Center | Epidemiology | |
Smoking Cessation in Vietnamese: A Controlled Trial | 1995 (Cycle 4) | $429,006 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
1994 (Cycle 3)
Smoking and Arterial Flux of Low Density Lipoprotein | 1994 (Cycle 3) | $274,674 |
University of California, Davis | Cardiovascular Disease | |
Regulation of Natural Killer Cell Activity by Theophylline | 1994 (Cycle 3) | $172,231 |
University of California, Los Angeles | Pulmonary Disease | |
Functional Synthetic Peptide Mimics of Apolipoprotein E | 1994 (Cycle 3) | $653,578 |
Scripps Research Institute | Cardiovascular Disease | |
Environmental Tobacco Smoke and Lung Cancer | 1994 (Cycle 3) | $234,432 |
University of California, Davis | Cancer | |
Oral Clefts, Candidate Genes, & Parental Tobacco Use | 1994 (Cycle 3) | $253,154 |
March of Dimes Birth Defects Foundation | Epidemiology | |
Desensitization of Cholinergic Mechanisms & Nicotine Addiction | 1994 (Cycle 3) | $267,178 |
University of California, Davis | Nicotine Dependence | |
Modeling US Lung Cancer Death Rates | 1994 (Cycle 3) | $158,756 |
University of California, San Diego | Epidemiology | |
Weight Gain as a Predictor of Smoking Relapse | 1994 (Cycle 3) | $750,320 |
SRI International | Tobacco-Use Prevention and Cessation | |
Diagnosis and Treatment of MTAse-Deficient Lung Cancers | 1994 (Cycle 3) | $370,631 |
University of California, San Diego | Cancer | |
Role of aV Integrins in Malignancy of Tobacco/Induced Tumors | 1994 (Cycle 3) | $485,909 |
Scripps Research Institute | Cancer | |
Smokeless Tobacco Cessation Among Lumber Mill Employees | 1994 (Cycle 3) | $159,203 |
University of Southern California | Tobacco-Use Prevention and Cessation | |
Smoking and Risk of Proximal Vs. Distal Gastric Cancer | 1994 (Cycle 3) | $835,887 |
University of Southern California | Epidemiology | |
Correlates of Smoking in Teen, Adult & Pregnant Women in CA | 1994 (Cycle 3) | $136,082 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Role of the Acetyl LDL Receptor in Atherogenesis | 1994 (Cycle 3) | $121,187 |
J. David Gladstone Institutes | Cardiovascular Disease | |
D2 Dopamine Receptor Alleles in Smokers & Nonsmokers | 1994 (Cycle 3) | $356,559 |
University of California, Los Angeles | Public Health, Public Policy, and Economics | |
Cell Adhesion Receptors in Atherogenesis | 1994 (Cycle 3) | $391,252 |
Scripps Research Institute | Cardiovascular Disease | |
Role of Nitric Oxide in Smoking-Related Vascular Impotence | 1994 (Cycle 3) | $531,486 |
LA Biomedical Research Institute at Harbor-UCLA Medical Center | Cardiovascular Disease | |
Periodic Gene Expression in the G1 Phase of the Cell Cycle | 1994 (Cycle 3) | $498,844 |
California Institute of Technology | Cancer | |
Acetylcholine Receptors in the Developing Nervous System | 1994 (Cycle 3) | $116,263 |
University of California, San Diego | Nicotine Dependence | |
Nicotine & Cocaine Dynamics: Patterns & Consequences | 1994 (Cycle 3) | $277,738 |
University of California, Los Angeles | Public Health, Public Policy, and Economics | |
Na/H Exchange in Hypoxic/Ischemic Myocardium: Effects on Ca | 1994 (Cycle 3) | $243,322 |
University of California, Davis | Cardiovascular Disease | |
Role of Protein Phosphatase 2A in Lung Carcinoma | 1994 (Cycle 3) | $342,144 |
University of California, San Diego | Cancer | |
Pathogenesis of Smoke-Induced Injury in Airway Epithelium | 1994 (Cycle 3) | $431,266 |
University of California, Davis | Pulmonary Disease | |
Tobacco Prevention for Hard to Reach Youth | 1994 (Cycle 3) | $224,497 |
San Diego State University Research Foundation | Tobacco-Use Prevention and Cessation | |
Environmental Tobacco Smoke and Fetal Growth Retardation | 1994 (Cycle 3) | $124,865 |
University of California, Davis | General Biomedical Science | |
Signal Transduction and Cell Activation | 1994 (Cycle 3) | $404,312 |
Salk Institute for Biological Studies | Cancer | |
Integrin Cytoplasmic Domains and Ligand Affinity Modulation | 1994 (Cycle 3) | $522,649 |
Scripps Research Institute | Cardiovascular Disease | |
Smoking Cessation After Surgery/A Randomized Trial | 1994 (Cycle 3) | $378,222 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Monocyte Chemoattractant Protein (MCP-1) in Atherosclerosis | 1994 (Cycle 3) | $484,207 |
J. David Gladstone Institutes | Cardiovascular Disease | |
Does TGF-b modulate Metastasis of Small Cell Lung Carcinoma | 1994 (Cycle 3) | $389,719 |
University of California, San Francisco | Cancer | |
The Character, Costs, and Impacts of Public Smoking Programs | 1994 (Cycle 3) | $137,264 |
University of California, Berkeley | Public Health, Public Policy, and Economics | |
Response of Respiratory Cancers to Novel Antiofolates | 1994 (Cycle 3) | $175,926 |
University of Southern California | Cancer | |
Radioimmunotherapy of Lung Cancer | 1994 (Cycle 3) | $318,994 |
University of Southern California | Cancer | |
Effects of Nicotine on Weight | 1994 (Cycle 3) | $136,752 |
Stanford University | General Biomedical Science | |
Sidestream Tobacco Smoke Dispersion and Inhalability | 1994 (Cycle 3) | $265,856 |
University of California, Irvine | General Biomedical Science | |
Sites of Chemoattractant Receptor Interaction with G Protein | 1994 (Cycle 3) | $720,174 |
Scripps Research Institute | Pulmonary Disease | |
Smoking Related Abnormalities of the Lung Surfactant System | 1994 (Cycle 3) | $438,278 |
University of California, San Diego | Pulmonary Disease | |
Effects of Tobacco Smoke on Proto-Oncogene Activity | 1994 (Cycle 3) | $382,758 |
University of California, San Diego | Cancer | |
Defensins and à 2-macroglobulin in Lung Inflammation | 1994 (Cycle 3) | $316,269 |
University of California, Los Angeles | Pulmonary Disease | |
Regulation of GP IIb-IIIa by the Platelet Cytoskeleton | 1994 (Cycle 3) | $537,597 |
Children's Hospital Oakland Research Institute | Cardiovascular Disease | |
Mechanism of Mitotic Chromosome Condensation | 1994 (Cycle 3) | $292,842 |
University of California, San Francisco | Cancer | |
Genetic Markers of Lung Cancer Risk Among Blacks & Whites | 1994 (Cycle 3) | $295,028 |
University of Southern California | Epidemiology | |
Cloning & Expression of the Apo-B mRNA Editing Factor | 1994 (Cycle 3) | $254,743 |
J. David Gladstone Institutes | Cardiovascular Disease | |
Tobacco Smoking & Genetic Alterations in Bladder Epithelium | 1994 (Cycle 3) | $282,853 |
University of California, San Francisco | Cancer | |
Role of Annexins in Neutrophil Degranulation | 1994 (Cycle 3) | $422,822 |
University of California, San Francisco | Pulmonary Disease | |
Smoking and HDL Cholesterol in Minority Youth | 1994 (Cycle 3) | $669,343 |
University of Southern California | Epidemiology | |
T-Cell Stimulating Antigen Genes in Tumor Cells | 1994 (Cycle 3) | $362,814 |
University of California, Berkeley | Cancer | |
The Dopamine D2 Receptor in Nicotine Addiction | 1994 (Cycle 3) | $162,870 |
City of Hope National Medical Center | Nicotine Dependence | |
Radioimmunotherapy & Hypoxic Cytotoxin in Squamous Cancer | 1994 (Cycle 3) | $157,321 |
SRI International | Cancer | |
Hormones and Tobacco: Joint Effects on Reproduction | 1994 (Cycle 3) | $263,611 |
Public Health Institute | Epidemiology | |
Mechanisms Underlying Smoking-Induced Oxidation of LDL | 1994 (Cycle 3) | $264,586 |
University of California, San Diego | Cardiovascular Disease | |
Effect of Maternal Smoking on Human Placental Development | 1994 (Cycle 3) | $406,527 |
University of California, San Francisco | General Biomedical Science | |
Cell Adhesion Receptors in Atherogenesis | 1994 (Cycle 3) | $170,341 |
The Burnham Institute for Medical Research | Cardiovascular Disease | |
Autocrine Interactions Between Bombesin and its Receptor | 1994 (Cycle 3) | $316,238 |
University of California, San Diego | Cancer | |
Tobacco Smoke Exposure & Chromosomally Defective Sperm | 1994 (Cycle 3) | $438,464 |
Lawrence Livermore National Laboratory | Epidemiology | |
1993 (Cycle 2)
The Effects of Tobacco Smoke on Airway Mucin mRNA | 1993 (Cycle 2) | $71,867 |
University of California, San Francisco | Pulmonary Disease | |
Health Related Quality of Life Outcomes of Smokers Who Quit | 1993 (Cycle 2) | $338,364 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Nicotinic Receptors, Tolerance and Spinal Neurotransmitters | 1993 (Cycle 2) | $320,869 |
University of California, San Diego | Nicotine Dependence | |
Structure-function studies of RAS nucleotide-exchange-factor | 1993 (Cycle 2) | $593,460 |
University of Southern California | Cancer | |
Nicotine Addiction: Novel ACh Receptors on Neurons | 1993 (Cycle 2) | $369,025 |
University of California, San Diego | Nicotine Dependence | |
Tobacco Induced Hypoxia: Molecular Genetic Responses | 1993 (Cycle 2) | $685,782 |
University of Southern California | Cardiovascular Disease | |
Clinician Initiated Smoking Prevention: A Controlled Trial | 1993 (Cycle 2) | $2,071,588 |
San Diego State University Research Foundation | Tobacco-Use Prevention and Cessation | |
Effect of Cigarette Smoke on Vascular Wall Permeability | 1993 (Cycle 2) | $99,854 |
University of California, Davis | Cardiovascular Disease | |
Smoke Induced Differntial Expression of Cellular Proteins | 1993 (Cycle 2) | $257,010 |
University of California, San Francisco | Pulmonary Disease | |
Smoking as a risk factor in the etiology of down syndrome | 1993 (Cycle 2) | $730,292 |
March of Dimes Birth Defects Foundation | Epidemiology | |
Statistics of Tobacco Smoke Exposure | 1993 (Cycle 2) | $910,542 |
Stanford University | Epidemiology | |
Sucellular Localization of CAMP-dependent Protein Kinase | 1993 (Cycle 2) | $338,472 |
University of California, San Diego | Cancer | |
The Effect of Cigarette Smoke on Airway Neuronal Receptors | 1993 (Cycle 2) | $225,260 |
University of California, San Francisco | Pulmonary Disease | |
Smoking and Leukemia: A Molecular Genetic Approach | 1993 (Cycle 2) | $334,253 |
University of California, Los Angeles | Cancer | |
Smoking Ordinances, Passive Smoking and Smoking Cessation | 1993 (Cycle 2) | $151,547 |
Molecular Medicine Research Institute | Public Health, Public Policy, and Economics | |
Radon Attachment to Cigarette Smoke Aerosols | 1993 (Cycle 2) | $344,430 |
Lawrence Livermore National Laboratory | General Biomedical Science | |
Effect of Single-Session Hypnosis on Smoking Cessation | 1993 (Cycle 2) | $610,950 |
Stanford University | Tobacco-Use Prevention and Cessation | |
Do Follow-up Visits Help Patients Quit Smoking? | 1993 (Cycle 2) | $745,189 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Fertility, Smoking, and Early Mammalian Development | 1993 (Cycle 2) | $166,751 |
University of California, Riverside | General Biomedical Science | |
Expression of a drug resistance gene in head and neck cancer | 1993 (Cycle 2) | $337,086 |
University of California, San Diego | Cancer | |
Activated Protein C in Smokers Thrombosis | 1993 (Cycle 2) | $347,737 |
Scripps Research Institute | Cardiovascular Disease | |
Role of Elastin Peptides in Neutrophil-Mediated Lung Injury | 1993 (Cycle 2) | $495,336 |
Childrens Hospital, Los Angeles | Pulmonary Disease | |
Angiotensin II and Restenosis after Coronary Angioplasty | 1993 (Cycle 2) | $228,018 |
University of California, Davis | Cardiovascular Disease | |
Effect of Cigarette Smoke on High Risk Lipoprotein Profiles | 1993 (Cycle 2) | $332,996 |
Lawrence Berkeley National Laboratory | Cardiovascular Disease | |
Smoking-Induced Impairment of Pulmonary Host Defense | 1993 (Cycle 2) | $381,970 |
University of California, Irvine | Pulmonary Disease | |
Vascular Effects of Nicotine: Effect of Age | 1993 (Cycle 2) | $331,124 |
University of California, Irvine | Nicotine Dependence | |
Regulation of Oxidant Production in Activated Phagocytes | 1993 (Cycle 2) | $540,379 |
Scripps Research Institute | Pulmonary Disease | |
Modeling U.S. Lung Cancer Death Rates | 1993 (Cycle 2) | $127,276 |
University of California, San Diego | Epidemiology | |
Smoking Cessation in Recovering Alcoholic Person (SCRAP) | 1993 (Cycle 2) | $835,924 |
San Diego State University Research Foundation | Tobacco-Use Prevention and Cessation | |
Tobacco Product Modulation of TNF Responses in Lung Cells | 1993 (Cycle 2) | $371,620 |
University of California, Riverside | General Biomedical Science | |
Determinants of Thrombin Interaction With Its Receptor | 1993 (Cycle 2) | $264,243 |
University of California, San Francisco | Cardiovascular Disease | |
Ethnicity and the Meaning of Smoking in Older Age Groups | 1993 (Cycle 2) | $317,076 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Relating Tobacco Access and Consumption Among Youth | 1993 (Cycle 2) | $489,771 |
Stanford University | Tobacco-Use Prevention and Cessation | |
Smoking-Related Advertising and Preteens' Social Perceptions | 1993 (Cycle 2) | $72,837 |
University of California, Irvine | Public Health, Public Policy, and Economics | |
Smoking and Lipoprotein-Based Mechanisms of Atherogenesis | 1993 (Cycle 2) | $250,645 |
University of California, San Francisco | Cardiovascular Disease | |
Modifiers of susceptibility to smoking for lung cancer | 1993 (Cycle 2) | $201,856 |
University of Southern California | Epidemiology | |
CNS effects of prenatal nicotine exposure: threshold dosage | 1993 (Cycle 2) | $458,763 |
LA Biomedical Research Institute at Harbor-UCLA Medical Center | Nicotine Dependence | |
Apolipoprotein(a) and Cardiovascular Disease | 1993 (Cycle 2) | $590,733 |
Stanford University | Cardiovascular Disease | |
Analysis of Retinoid Mediated Anti-cancer Activities | 1993 (Cycle 2) | $757,415 |
The Burnham Institute for Medical Research | Cancer | |
Phosphoryl Peptide Inhibitors of Tyrosine Kinases | 1993 (Cycle 2) | $308,697 |
University of California, San Francisco | Cancer | |
Oral Cancer: Adhesive Interactions During Progression | 1993 (Cycle 2) | $182,765 |
University of California, San Francisco | Cancer | |
Advances in Lung Cancer Detection with Digital Techniques | 1993 (Cycle 2) | $276,730 |
University of California, Los Angeles | Cancer | |
Tobacco Smoke and Airway Fluid Transport & Composition | 1993 (Cycle 2) | $301,622 |
University of California, Riverside | Pulmonary Disease | |
Nicotine, Tobacco Smoke and the Blood-Brain Barrier | 1993 (Cycle 2) | $624,017 |
University of Southern California | Nicotine Dependence | |
Measurement & Outcomes of Dyspnea in COPD | 1993 (Cycle 2) | $193,253 |
University of California, San Diego | Pulmonary Disease | |
Control of breathing in infants of smoking mothers | 1993 (Cycle 2) | $290,986 |
California Pacific Medical Center Research Institute | Epidemiology | |
Steroid Influences on Diaphragm Performance in Emphysema | 1993 (Cycle 2) | $343,914 |
Cedars-Sinai Medical Center | Pulmonary Disease | |
Asymmetric Synthesis of (-)-Podophyllotoxin | 1993 (Cycle 2) | $121,946 |
University of California, Santa Cruz | Cancer | |
The Cost of Passive Smoking on Children's Health | 1993 (Cycle 2) | $242,086 |
RAND Corporation | Public Health, Public Policy, and Economics | |
Tobacco-Related Disease Trends among 118,000 Californians | 1993 (Cycle 2) | $236,471 |
University of California, Los Angeles | Epidemiology | |
1992 (Cycle 1)
Risks for Selected Birth Defects from Parental Cig Smoke | 1992 (Cycle 1) | $560,383 |
March of Dimes Birth Defects Foundation | Epidemiology | |
A Smokeless Tobacco Cessation Intervention: College Athletes | 1992 (Cycle 1) | $648,997 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Control of Mucociliary Clearance in the Respiratory Tract | 1992 (Cycle 1) | $404,950 |
University of California, Los Angeles | Pulmonary Disease | |
The Accumbens: A Critical Brain Site for Nicotine Craving | 1992 (Cycle 1) | $532,964 |
Scripps Research Institute | Nicotine Dependence | |
Involvement of the Tumor Suppressor Gene p53 in Lung Cancer | 1992 (Cycle 1) | $112,504 |
University of California, Irvine | Cancer | |
Integrin Distribution & Function in Lung Carcinoma Cells | 1992 (Cycle 1) | $358,128 |
University of California, San Francisco | Cancer | |
Smoking-Induced Mod. of Resp. Burst Oxidase of Human Phagocy | 1992 (Cycle 1) | $298,435 |
University of California, San Diego | Pulmonary Disease | |
Differentiating Preadolescent/Adolescent Paths to Smoking | 1992 (Cycle 1) | $459,986 |
University of Southern California | Public Health, Public Policy, and Economics | |
Vietnamese Smoking Cessation Intervention: A Controlled Trial | 1992 (Cycle 1) | $707,559 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Clinical Pharmacology of Tobacco Alkaloids | 1992 (Cycle 1) | $538,143 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Effects of Smoking on Metabolism During Rest & Exercise | 1992 (Cycle 1) | $504,382 |
University of California, Berkeley | Pulmonary Disease | |
Effects of Tobacco on Rat Lung Alveolar Lining Liquid | 1992 (Cycle 1) | $417,585 |
Lawrence Berkeley National Laboratory | Pulmonary Disease | |
Amnesty Smoking Prevention Project | 1992 (Cycle 1) | $686,087 |
University of Southern California | Tobacco-Use Prevention and Cessation | |
Suppression of Oncogenic RAS Mutations | 1992 (Cycle 1) | $355,159 |
University of California, Berkeley | Cancer | |
Adenosine Airway Reactivity & Receptors in Smokers | 1992 (Cycle 1) | $93,500 |
University of California, Davis | Pulmonary Disease | |
Interaction of Complement C4b-Binding Protein with Protein B | 1992 (Cycle 1) | $616,016 |
Scripps Research Institute | General Biomedical Science | |
Passive Smoking & Clara Cell Developement in the Lungs | 1992 (Cycle 1) | $435,023 |
University of California, Davis | Pulmonary Disease | |
Impact of Caffeine Use On Tobacco Cessation & Withdrawal | 1992 (Cycle 1) | $377,968 |
Loma Linda University | Tobacco-Use Prevention and Cessation | |
Interaction of Occupational Aerosols & Tobacco Smoke | 1992 (Cycle 1) | $192,878 |
University of California, Los Angeles | General Biomedical Science | |
Factors Required for K-RAS 4B Membrane Association/Activity | 1992 (Cycle 1) | $600,414 |
Scripps Research Institute | General Biomedical Science | |
Environmental & Genetic Risk Factors for Bladder Cancer | 1992 (Cycle 1) | $1,147,940 |
University of Southern California | Epidemiology | |
Tobacco Industry Response to Passive Smoking | 1992 (Cycle 1) | $484,233 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Effects of Nicotine on Human Information Processing | 1992 (Cycle 1) | $247,818 |
Northern California Institute for Research & Education | Public Health, Public Policy, and Economics | |
Laryngeal Cancer Risk Factors: Tobacco Interactions | 1992 (Cycle 1) | $720,644 |
Public Health Institute | Epidemiology | |
An Endogenous Lectin in Airway Epithelium & Lung Cancer | 1992 (Cycle 1) | $463,703 |
University of California, San Francisco | Pulmonary Disease | |
Roles of Hypoxia, Nicotine & cAMP in Ischemic Heart Failure | 1992 (Cycle 1) | $713,367 |
SRI International | Cardiovascular Disease | |
Reduction of Passive Smoking in Asthmatic Children: Clinical | 1992 (Cycle 1) | $521,489 |
San Diego State University Research Foundation | Tobacco-Use Prevention and Cessation | |
Optim. of Train. in Patients w/Chronic Obstruc. Pulm Disease | 1992 (Cycle 1) | $467,503 |
Cedars-Sinai Medical Center | Pulmonary Disease | |
Prospective Study of Cigarette Smoking & Behavior Dysfunction | 1992 (Cycle 1) | $500,370 |
University of California, Berkeley | Public Health, Public Policy, and Economics | |
Pathways for Reverse Cholesterol Transport | 1992 (Cycle 1) | $265,990 |
University of California, San Diego | Cardiovascular Disease | |
Smoking & Passive Smoking Patterns in Chinese Americans | 1992 (Cycle 1) | $524,884 |
Public Health Institute | Epidemiology | |
Novel Approach to Head & Neck Cancer Therapy | 1992 (Cycle 1) | $384,743 |
University of Southern California | Cancer | |
Tumor Suppressor Genes in Human Lung Cancer | 1992 (Cycle 1) | $319,060 |
University of California, Irvine | Cancer | |
Determinants of Susceptibilty to Oxidixed Lipoproteins | 1992 (Cycle 1) | $324,569 |
University of California, Los Angeles | Cardiovascular Disease | |
Tobacco Cessation Among Pregnant Low-Income Latino Women | 1992 (Cycle 1) | $737,927 |
University of Southern California | Tobacco-Use Prevention and Cessation | |
Tobacco-Related Disease in Native California Twins | 1992 (Cycle 1) | $634,515 |
University of Southern California | Epidemiology | |
Tobacco Carcinogen Transformation of Human Bronchial Cells | 1992 (Cycle 1) | $621,592 |
University of Southern California | Cancer | |
Effect of Tobacco in Cervical Neoplasia in Young Women | 1992 (Cycle 1) | $959,796 |
University of California, San Francisco | Epidemiology | |
Surveillance for Tobacco-Related Diseases | 1992 (Cycle 1) | $627,384 |
Public Health Institute | Public Health, Public Policy, and Economics | |
Controlling Exposure to Environmental Tobacco Smoke | 1992 (Cycle 1) | $205,357 |
University of California, Berkeley | General Biomedical Science | |
Cigarette Smoke, Nicotine & Acid-induced Duodenal Injury | 1992 (Cycle 1) | $311,797 |
University of California, Los Angeles | General Biomedical Science | |
Vascular Response to Injury: Potentiation by Nicotine | 1992 (Cycle 1) | $572,478 |
Stanford University | Cardiovascular Disease | |
Nicotinic Effects on Gene Expression in PC-12 Cells | 1992 (Cycle 1) | $266,647 |
University of California, San Diego | Nicotine Dependence | |
Substrate Cycles, Calorigenesis & Smoking Cessation | 1992 (Cycle 1) | $378,709 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Prop 99 & Indigent Care: Lessons for Future Health Care Reform | 1992 (Cycle 1) | $589,892 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Novel Imuunotherapy for Small Cell Lung Carcinoma | 1992 (Cycle 1) | $496,569 |
Childrens Hospital, Los Angeles | Cancer | |
Modifiers of Susceptibility to Smoking for Lung Cancer | 1992 (Cycle 1) | $79,865 |
University of Southern California | Epidemiology | |
Effects of Prenatal Nicotine Exposure in Brain Development | 1992 (Cycle 1) | $750,511 |
University of Southern California | General Biomedical Science | |
Nicotine Levels in Pregnant Women & Child Development | 1992 (Cycle 1) | $335,068 |
University of California, Berkeley | Epidemiology | |
Management of Smoking by the Elderly in Long Term Care | 1992 (Cycle 1) | $498,334 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Gene Modification of Human Lung Tumor-Infiltrating Lymphocyte | 1992 (Cycle 1) | $152,816 |
University of California, Los Angeles | Cancer | |
Nicotine Effects on Activity of Brain Catecholamine Neurons | 1992 (Cycle 1) | $317,443 |
University of California, San Diego | Nicotine Dependence | |
Lung Cancer Associated Retinopathy | 1992 (Cycle 1) | $352,945 |
University of California, Davis | Cancer | |
Role of Nicotine in Enodthelial Cell Function | 1992 (Cycle 1) | $274,274 |
University of Southern California | Cardiovascular Disease | |
Molecular Mechanisms of Leukocyte Traffic to the Lungs | 1992 (Cycle 1) | $345,676 |
Stanford University | Pulmonary Disease | |
Laboratory & Ambulatory Assessment of Smoking Withdrawal | 1992 (Cycle 1) | $385,814 |
SRI International | Tobacco-Use Prevention and Cessation | |
Detrimental Influence of NO on Vascular/Platelet Functions | 1992 (Cycle 1) | $288,188 |
University of California, Los Angeles | Cardiovascular Disease | |
Nicotine & Early Response Gene Expression in Brain | 1992 (Cycle 1) | $99,290 |
University of California, San Francisco | Nicotine Dependence | |
Doses to Target Tissues from Inhaled Tobacco Smoke | 1992 (Cycle 1) | $413,410 |
University of California, Irvine | General Biomedical Science | |
In Vitro Characterization of Human Airway Gland Cells | 1992 (Cycle 1) | $511,793 |
University of California, San Francisco | Pulmonary Disease | |
Cost of Smoking in California | 1992 (Cycle 1) | $185,697 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Meta-Analysis of Prop 99 Competitive Grant Funded Projects | 1992 (Cycle 1) | $232,993 |
University of California, Berkeley | Public Health, Public Policy, and Economics | |
Peptidyl Phosphonate Inhibitors to Human Leukocyte Elastase | 1992 (Cycle 1) | $359,461 |
SRI International | General Biomedical Science | |
Pathogenesis of Cigarette Smoke-Induced Bronchitis | 1992 (Cycle 1) | $487,719 |
University of California, Davis | Pulmonary Disease | |
Case study on tobacco use legislation | 1992 (Cycle 1) | $160,907 |
RAND Corporation | Public Health, Public Policy, and Economics | |
Pulmonary Benzo(A)pyrene Metabolism & Tobacco Smoking | 1992 (Cycle 1) | $303,996 |
University of California, Irvine | Pulmonary Disease | |
Novel Benzoxazinone Inhibitors to Hunam Leukocyte Elastase | 1992 (Cycle 1) | $332,615 |
SRI International | General Biomedical Science | |
Nicotine, Hypertension & Induction of Aortic Disease | 1992 (Cycle 1) | $182,010 |
University of California, Davis | Cardiovascular Disease | |
Experimental Approach to Tobacco Control for High-Risk Teens | 1992 (Cycle 1) | $672,155 |
San Diego State University Research Foundation | Tobacco-Use Prevention and Cessation | |
Effects of Nicotine on Human Information Processing | 1992 (Cycle 1) | $91,817 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Benzo[A]pyrene: Biogenetic Effects on Hepatocytes in Vitro | 1992 (Cycle 1) | $482,971 |
University of California, San Diego | General Biomedical Science | |
Control of Differentiation of the Early Embryonic Heart | 1992 (Cycle 1) | $191,398 |
California Institute of Technology | Cardiovascular Disease | |
Oxygen Effects on Flow & function in Ischemic Myocardium | 1992 (Cycle 1) | $278,044 |
University of California, San Francisco | Cardiovascular Disease | |
Effectiveness Ventilation & other Controls in Reducing ETS | 1992 (Cycle 1) | $522,494 |
Public Health Foundation Enterprises, Inc. | General Biomedical Science | |
Studies of Proto-oncogenes & Growth Genes in Human Lung Cancer | 1992 (Cycle 1) | $336,209 |
University of California, Los Angeles | Cancer | |
Analysis of the Effect of National Policies on Smoking Behavior | 1992 (Cycle 1) | $579,489 |
University of California, San Diego | Public Health, Public Policy, and Economics | |
Thrombin Function/Inhibition in Tobacco-Related Diseases | 1992 (Cycle 1) | $578,441 |
SRI International | Cardiovascular Disease | |
The Relationship of Tobacco Exposure to Semen Biomarkers | 1992 (Cycle 1) | $186,739 |
University of California, San Francisco | Epidemiology | |
Hemoglobin Conversion to Pro-Oxidants by Cigarette Smoke | 1992 (Cycle 1) | $313,201 |
Lawrence Berkeley National Laboratory | General Biomedical Science | |
Optical Partical Size Measurements of Tobacco Smoke | 1992 (Cycle 1) | $103,468 |
University of California, Irvine | General Biomedical Science | |
Lung Cancer: p53 as a Paradigm of Tumor Suppression | 1992 (Cycle 1) | $138,420 |
Cedars-Sinai Medical Center | Cancer | |
Phenols & PAH in Tobacco-Related Cardiovascular Disease | 1992 (Cycle 1) | $421,763 |
University of Southern California | Cardiovascular Disease | |
Pulmonary Vascular Leukocytes & Tobacco Products | 1992 (Cycle 1) | $435,721 |
University of California, Irvine | Pulmonary Disease | |
Regulation of the Nicotinic Receptors by Nicotine | 1992 (Cycle 1) | $756,102 |
Salk Institute for Biological Studies | Nicotine Dependence | |
Cigarette Smoking & Facial Wrinkling | 1992 (Cycle 1) | $515,796 |
University of California, San Francisco | Epidemiology | |
Cigarette Smoking & Sudden Cardiac Death | 1992 (Cycle 1) | $783,629 |
University of California, San Francisco | Epidemiology | |
Neutrophil Cytostatic Activity Against Lung Tumor Cells | 1992 (Cycle 1) | $223,628 |
University of California, Los Angeles | Cancer | |
Significance of Immune Complexes in Human Lung Carcinoma | 1992 (Cycle 1) | $249,402 |
John Wayne Cancer Institute | Cancer | |
Tumor Infiltrating Lymphocytes & Pulmonary Macrophages | 1992 (Cycle 1) | $423,786 |
University of California, Los Angeles | Cancer | |
Nicotine Enhanced Adrenal Medullary-Dependent Inflammation | 1992 (Cycle 1) | $363,563 |
University of California, San Francisco | Nicotine Dependence | |
Smoking, Immunoglobulin E, & Cardiovascular Disease | 1992 (Cycle 1) | $49,517 |
University of California, San Diego | Epidemiology | |
Assessing Tobacco Refusal Skills in Latino Youth | 1992 (Cycle 1) | $584,719 |
San Diego State University Research Foundation | Public Health, Public Policy, and Economics | |
Vaccine Strategy Against Tumor-Associated Glycoproteins | 1992 (Cycle 1) | $285,227 |
University of California, San Diego | Cancer | |
Cigarette Smoking, Steroidogenesis & Steroid Receptors | 1992 (Cycle 1) | $316,942 |
Stanford University | General Biomedical Science | |
Genetic Aberrations in Tobacco-Related Lung Carcinogenesis | 1992 (Cycle 1) | $214,126 |
University of Southern California | Cancer | |
Filipino Smoking Prevalance Survey in California | 1992 (Cycle 1) | $153,533 |
Asian & Pacific Islander American Health Forum | Epidemiology | |
Pregnant Smokers: Predictors of Cessation & Relapse | 1992 (Cycle 1) | $451,831 |
University of California, San Francisco | Tobacco-Use Prevention and Cessation | |
Precursors & Correlates of Smoking in Adolescents | 1992 (Cycle 1) | $63,786 |
Molecular Medicine Research Institute | Epidemiology | |
Effects of Smoking on High Density Lipoprotein Species | 1992 (Cycle 1) | $203,942 |
University of California, San Francisco | Cardiovascular Disease | |
Monoclonal Antibody-Drug Conjugate Treatment of Lung Cancer | 1992 (Cycle 1) | $258,750 |
Scripps Clinic & Research Foundation | Cancer | |
Modulatory Effects of Tobacco Products in Immune Function | 1992 (Cycle 1) | $85,387 |
University of California, San Diego | General Biomedical Science | |
Tobacco Smoke: Mechanistic Roles in COPD | 1992 (Cycle 1) | $250,297 |
University of California, Davis | Pulmonary Disease | |
The Role of Sleep in Successful Smoking Cessation | 1992 (Cycle 1) | $180,399 |
Long Beach Research Foundation | Tobacco-Use Prevention and Cessation | |
Tobacco Smoke, Free Radicals, Antioxidants & Disease | 1992 (Cycle 1) | $215,713 |
University of California, Berkeley | Pulmonary Disease | |
Self Management for Tobacco-Related Chronic Diseases | 1992 (Cycle 1) | $1,049,257 |
Stanford University | Public Health, Public Policy, and Economics | |
Mechanism of Endothelin-Stimulated ANF Secretion | 1992 (Cycle 1) | $447,480 |
San Diego State University Research Foundation | Cardiovascular Disease | |
Effects of Smoke on Fluid Transport Across Trachea | 1992 (Cycle 1) | $395,115 |
University of California, Berkeley | Pulmonary Disease | |
Physician Incentives & Smoking Cessation Effectiveness | 1992 (Cycle 1) | $745,316 |
University of Southern California | Tobacco-Use Prevention and Cessation | |
The Economic Effects of California Cigarette Taxation | 1992 (Cycle 1) | $474,976 |
University of California, Berkeley | Public Health, Public Policy, and Economics | |
Characterization of Particulate-Phase ETS in Differing Environments | 1992 (Cycle 1) | $454,509 |
Lawrence Berkeley National Laboratory | General Biomedical Science | |
Predictors of Weight Gain After Smoking Cessation | 1992 (Cycle 1) | $809,412 |
Kaiser Foundation Research Institute | Tobacco-Use Prevention and Cessation | |
Comparison of Nicotine Metabolism in four Ethnic Groups | 1992 (Cycle 1) | $449,327 |
University of California, San Francisco | Public Health, Public Policy, and Economics | |
Effects of Passive Smoking on Experimental Atherosclerosis | 1992 (Cycle 1) | $340,594 |
University of California, San Francisco | Cardiovascular Disease | |
A Genetic Marker of Lung Cancer Risk Among Blacks & Whites | 1992 (Cycle 1) | $1,036,615 |
University of Southern California | Epidemiology | |
The Mechanism of Nicotine-Induced Gastric Mucosal Injury | 1992 (Cycle 1) | $221,032 |
University of California, Los Angeles | General Biomedical Science | |
CNS Processing of Lung Afferent & Cigarette Smoke Inputs | 1992 (Cycle 1) | $261,726 |
University of California, Davis | Pulmonary Disease | |
Effects of Social & Personal Coping Programs for Smok Prevention | 1992 (Cycle 1) | $676,689 |
University of Southern California | Tobacco-Use Prevention and Cessation | |
Environmental Tobacco Smoke & Lung Development | 1992 (Cycle 1) | $512,031 |
University of California, Irvine | Pulmonary Disease | |
Carotid Body Amplification of Exertional Dyspnea in Smokers | 1992 (Cycle 1) | $196,560 |
University of California, Los Angeles | Pulmonary Disease | |
Complement Mediated Cardiac Ischemei & Thromboxane Release | 1992 (Cycle 1) | $291,601 |
Veterans Medical Research Foundation | Cardiovascular Disease | |
Tobacco & Its Releated Diseases: Law, Policy & Politics | 1992 (Cycle 1) | $218,932 |
University of California, Berkeley | Public Health, Public Policy, and Economics | |
Early Detection of Lung Cancer with Monoclonal Antibodies | 1992 (Cycle 1) | $860,784 |
University of California, Los Angeles | Cancer | |
Cloning of Two Genes Involved it Tobacco Carcinogenesis | 1992 (Cycle 1) | $323,634 |
University of California, Los Angeles | Cancer | |
Tobacco Carcinogens/C-Kinase Oxidative Activation/Metastasis | 1992 (Cycle 1) | $363,557 |
University of Southern California | Cancer | |
Smoking Effects on Maternal Folate & Reproductive Outcomes | 1992 (Cycle 1) | $105,988 |
University of California, Davis | Epidemiology | |
Black-White Differences in Menthol Cigarette Smoking | 1992 (Cycle 1) | $332,764 |
University of California, Los Angeles | Public Health, Public Policy, and Economics | |
Determinants of Maximum Oxygen Transport. | 1992 (Cycle 1) | $282,699 |
University of California, San Diego | Pulmonary Disease | |
Lung Cancer: p53 as a Paradigm of Tumor Suppression | 1992 (Cycle 1) | $327,795 |
University of California, Los Angeles | Cancer | |
Hospital-Based Intervention to Prevent Smoking Relapse | 1992 (Cycle 1) | $676,939 |
Stanford University | Tobacco-Use Prevention and Cessation | |
Protection of Lung Epithelium by Heat Shock Proteins | 1992 (Cycle 1) | $357,085 |
University of California, Irvine | Pulmonary Disease | |
Heterologous Expression of Brain Nicotinic Receptors | 1992 (Cycle 1) | $586,840 |
California Institute of Technology | Nicotine Dependence | |
Role of Smoking in Progression of Anal Neoplasia | 1992 (Cycle 1) | $638,812 |
University of California, San Francisco | Epidemiology | |
Smoking & Adverse Reproductive Health Effects in Women | 1992 (Cycle 1) | $550,243 |
University of California, Davis | Epidemiology | |
Smoking & Atherosclerosis--An Autoimmune Phenomenon? | 1992 (Cycle 1) | $151,149 |
University of California, Davis | Cardiovascular Disease | |
Significance of Immune Complexes in Human Lung Carcinoma | 1992 (Cycle 1) | $111,083 |
University of California, Los Angeles | Pulmonary Disease | |
Stress & Smoking in Natural Settings: An Ambulatory Study | 1992 (Cycle 1) | $489,853 |
University of California, Los Angeles | Public Health, Public Policy, and Economics | |
Effects of Sedatives on Neuronal Nicotinic Binding | 1992 (Cycle 1) | $394,301 |
University of California, San Francisco | Nicotine Dependence | |